MASS GENERAL BRIGHAM INCORPORATED: Form 990, tax year 2012

View the entire original 990 at ProPublica ↗

Organization: MASS GENERAL BRIGHAM INCORPORATED (EIN 04-2103591)
Tax period: 2012-10-01 to 2013-09-30
Filed: 2014-08-15
IRS object ID: 201442279349303459
Schema version: 2012v2.3
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule H
Schedule I
Schedule J
Schedule K
Schedule L
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2014-08-15T13:04:39-05:00	Timestamp
Tax Period End Date	2013-09-30	TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	PricewaterhouseCoopers LLP	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	125 High Street	AddressLine1
City	Boston	City
State	MA	State
ZIP Code	02110	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2012-10-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	042103591	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	MASSACHUSETTS EYE & EAR INFIRMARY	BusinessNameLine1

Field	Value	IRS element (for citing)
In Care Of Name	% CAROLANN WILLIAMS	InCareOfName
Name Control	MASS	NameControl
Phone	6175733942	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	243 CHARLES STREET	AddressLine1
Address Line2	Suite	AddressLine2
City	BOSTON	City
State	MA	State
ZIP Code	02114	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	CAROLANN WILLIAMS	Name
Title	CFO & VP FIN AND ADMIN	Title
Phone	6175733942	Phone
Date Signed	2014-07-09	DateSigned
Authorize Third Party	true	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Phone	6175305000	Phone

Field	Value	IRS element (for citing)
Tax Year	2012	TaxYear
Build TS	2015-11-30 17:44:51Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	CAROLANN WILLIAMS	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	243 CHARLES STREET	AddressLine1
City	BOSTON	City
State	MA	State
ZIP Code	02114	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	221665628	GrossReceipts
Group Return For Affiliates	false	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	WWW.MASSEYEANDEAR.ORG	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1827	YearFormation
State Legal Domicile	MA	StateLegalDomicile
Activity Or Mission Description	SEE SCHEDULE O.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	21	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	18	NbrIndependentVotingMembers
Total Nbr Employees	1965	TotalNbrEmployees
Total Nbr Volunteers	279	TotalNbrVolunteers
Total Gross UBI	0	TotalGrossUBI
Contributions Grants Prior Year	33572100	ContributionsGrantsPriorYear
Contributions Grants Current Year	39413484	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	150956667	ProgramServiceRevenuePriorYear
Program Service Revenue CY	164905375	ProgramServiceRevenueCY
Investment Income Prior Year	665789	InvestmentIncomePriorYear
Investment Income Current Year	1067489	InvestmentIncomeCurrentYear
Other Revenue Prior Year	15017611	OtherRevenuePriorYear
Other Revenue Current Year	16279280	OtherRevenueCurrentYear
Total Revenue Prior Year	200212167	TotalRevenuePriorYear
Total Revenue Current Year	221665628	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	15552737	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	16717561	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	100490121	SalariesEtcPriorYear
Salaries Etc Current Year	106973420	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	256235	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	278479	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	2020705	TotalFundrsngExpCurrentYear
Other Expense Prior Year	84181529	OtherExpensePriorYear
Other Expenses Current Year	98774910	OtherExpensesCurrentYear
Total Expenses Prior Year	200480622	TotalExpensesPriorYear
Total Expenses Current Year	222744370	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	-268455	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	-1078742	RevenuesLessExpensesCY
Total Assets BOY	236179653	TotalAssetsBOY
Total Assets EOY	224049415	TotalAssetsEOY
Total Liabilities BOY	210336333	TotalLiabilitiesBOY
Total Liabilities EOY	187529630	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	25843320	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	36519785	NetAssetsOrFundBalancesEOY
Info In Schedule O Part III	X	InfoInScheduleOPartIII
Mission Description	SEE SCHEDULE O.	MissionDescription
Significant New Program Services	false	SignificantNewProgramServices
Significant Change	false	SignificantChange
Expense	44248600	Expense
Grants	6979955	Grants
Revenue	164905375	Revenue
Description	SEE SCHEDULE O	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	4305552	Expense
Description	SEE SCHEDULE O	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	115469497	Expense
Grants	9737606	Grants
Description	SEE SCHEDULE O	Description

Field	Value	IRS element (for citing)
Total Program Service Expense	164023649	TotalProgramServiceExpense
Described In501 C3	true	DescribedIn501C3
Schedule B Required	true	ScheduleBRequired
Political Activities	false	PoliticalActivities
Lobbying Activities	true	LobbyingActivities
Subject To Proxy Tax	false	SubjectToProxyTax
Donor Advised Funds	false	DonorAdvisedFunds
Conservation Easements	false	ConservationEasements
Collections Of Art	true	CollectionsOfArt
Credit Counseling	false	CreditCounseling
Term Or Permanent Endowments	true	TermOrPermanentEndowments
Report Land Bldg Equip	true	ReportLandBldgEquip
Report Invest Oth Securities	false	ReportInvestOthSecurities
Report Prog Rel Invest	false	ReportProgRelInvest
Report Other Assets	true	ReportOtherAssets
Report Other Liabilities	true	ReportOtherLiabilities
Report Fin48 Footnote	true	ReportFin48Footnote
Independent Audit Financial Stmt	false	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	true	ConsolidatedAuditFinancialStmt
School	false	School
Foreign Office	false	ForeignOffice
Foreign Activities	true	ForeignActivities
More Than5000 K To Organizations	true	MoreThan5000KToOrganizations
More Than5000 K To Individuals	false	MoreThan5000KToIndividuals
Professional Fundraising	true	ProfessionalFundraising
Fundraising Activities	false	FundraisingActivities
Gaming	false	Gaming
Hospital	true	Hospital
Financial Stmt Attached	true	FinancialStmtAttached
Grants To Organizations	true	GrantsToOrganizations
Grants To Individuals	false	GrantsToIndividuals
Schedule J Required	true	ScheduleJRequired
Tax Exempt Bonds	true	TaxExemptBonds
Invest Tax Exempt Bonds	false	InvestTaxExemptBonds
Escrow Account	false	EscrowAccount
On Behalf Of Issuer	false	OnBehalfOfIssuer
Excess Benefit Transaction	false	ExcessBenefitTransaction
Prior Excess Benefit Transaction	false	PriorExcessBenefitTransaction
Loan To Officer Or DQP	true	LoanToOfficerOrDQP
Grant To Related Person	false	GrantToRelatedPerson
Bsnss Rltnshp With Organization	true	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	false	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	false	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	false	DeductibleNonCashContributions
Deductible Contributions Of Art	false	DeductibleContributionsOfArt
Terminated	false	Terminated
Partial Liquidation	false	PartialLiquidation
Disregarded Entity	false	DisregardedEntity
Related Entity	true	RelatedEntity
Related Org Controlled Entity	true	RelatedOrgControlledEntity
Transaction Related Entity	true	TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org	true	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	false	ActivitiesConductedPartnership
Schedule O Required	true	ScheduleORequired
Number Forms Transmitted With1096	148	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	true	ComplianceWithBackupWitholding
Number Of Employees	1965	NumberOfEmployees
Employment Tax Returns Filed	true	EmploymentTaxReturnsFiled
Unrelated Business Income	false	UnrelatedBusinessIncome
Foreign Financial Account	false	ForeignFinancialAccount
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTrans
Taxable Party Notification	false	TaxablePartyNotification
Non Deductible Contributions	false	NonDeductibleContributions
Quid Pro Quo Contributions	false	QuidProQuoContributions
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOf
Funds To Pay Premiums	false	FundsToPayPremiums
Premiums Paid	false	PremiumsPaid
Indoor Tanning Services	false	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	21	NbrVotingGoverningBodyMembers
Number Independent Voting Members	18	NumberIndependentVotingMembers
Family Or Business Relationship	false	FamilyOrBusinessRelationship
Delegation Of Management Duties	false	DelegationOfManagementDuties
Changes To Organizing Docs	false	ChangesToOrganizingDocs
Material Diversion Or Misuse	false	MaterialDiversionOrMisuse
Members Or Stockholders	false	MembersOrStockholders
Election Of Board Members	true	ElectionOfBoardMembers
Decisions Subject To Approval	true	DecisionsSubjectToApproval
Minutes Of Governing Body	true	MinutesOfGoverningBody
Minutes Of Committees	true	MinutesOfCommittees
Officer Mailing Address	false	OfficerMailingAddress
Local Chapters	false	LocalChapters
Form990 Provided To Governing Body	true	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	true	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	true	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	true	RegularMonitoringEnforcement
Whistleblower Policy	true	WhistleblowerPolicy
Document Retention Policy	true	DocumentRetentionPolicy
Compensation Process CEO	true	CompensationProcessCEO
Compensation Process Other	true	CompensationProcessOther
Investment In Joint Venture	false	InvestmentInJointVenture
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Field	Value	IRS element (for citing)
Name Person	CAROLANN WILLIAMS	NamePerson
Telephone Number	6175733012	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	243 CHARLES STREET	AddressLine1
City	BOSTON	City
State	MA	State
ZIP Code	02114	ZIPCode

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	X	InfoInScheduleOPartVII

Form990 Part VII Section A Form990PartVIISectionA (40 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Average Hours Per Week RelatedAverageHoursPerWeekRelated	Individual Trustee Or DirectorIndividualTrusteeOrDirector	OfficerOfficer	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee	FormerFormer
JOHN R FERNANDEZ
PRESIDENT	37.0	23.0	X	X	810694	0	155041
WYCLIFFE GROUSBECK
CHAIR	3.0	7.0	X	X
JONATHAN UHRIG
TREASURER	3.0	7.0	X	X
LILY H BENTAS
SECRETARY	3.0	7.0	X	X
RICHARD H ALDRICH
DIRECTOR	2.0	2.0	X
DEWALT PETE ANKENY
DIRECTOR	2.0	6.0	X
JAMES CARLISLE
DIRECTOR	2.0	2.0	X
CHARLES DE GUNZBERG
DIRECTOR	2.0	6.0	X
SAMUEL FLEMING
DIRECTOR	2.0	2.0	X
HARVEY FREISHTAT
DIRECTOR	2.0	2.0	X
LYLE HOWLAND
DIRECTOR	2.0	2.0	X
DIANE E KANEB
DIRECTOR	2.0	2.0	X
JONATHAN KUTCHINS
DIRECTOR	2.0	4.0	X
VICTORIA MCCULLOUGH
DIRECTOR	2.0	6.0	X
JOAN W MILLER MD
DIRECTOR	27.0	33.0	X		0	781005	56306
JOSEPH B NADOL JR MD
DIRECTOR	29.0	31.0	X		0	782173	62754
ANNETTE NOVA
DIRECTOR	2.0	6.0	X
WILLIAM ROMAN
DIRECTOR	2.0	2.0	X
FREDERICK THORNE
DIRECTOR	2.0	2.0	X
KATHRYN VECELLIO
DIRECTOR	2.0	6.0	X
EUGENE HILL
Director	2.0	2.0	X
SUSAN WILLIAMS
ASST SEC/GENERAL COUNSEL	49.0	11.0		X	268612	0	19064
MAUREEN KELLEY
ASST SECRETARY	53.0	7.0		X	172383	0	28262
CAROLANN WILLIAMS
CFO & VP FINANCE AND ADMIN	49.0	11.0		X	360843	0	11502
BARBARA J SCULLY
DIRECTOR PROF REV CYCLE	30.0	30.0			169929	0	34459	X
EILEEN O LOWELL
CNO & VP PAT CARE SVS	60.0	0.0			241312	0	33911	X
ALAN K LONG
VP RESEARCH ADMINISTRATION	30.0	30.0			221708	0	8547	X
CHRISTINE REGAN
VP HUMAN RESOURCES	60.0	0.0			237749	0	35375	X
KENNETH HOLMES
CFO MEEA	30.0	30.0			295103	0	28619	X
JEAN E MACQUIDDY
VP OTOLARYNGOLOGY	30.0	30.0			250249	0	33842	X
JEFFREY J PIKE
CHIEF OPERATING OFFICER	60.0	0.0			346471	0	18943	X
JAVIER BALLOFFET
VP OPHTHALMOLOGY	20.0	40.0			313354	0	36405	X
RALPH T PELOSI
DIRECTOR FACILITIES PLANNING	60.0	0.0			173928	0	6476	X
JENNIFER STREET
VP COMMUNICATIONS & PLANNING	60.0	0.0			339166	0	33000		X
MELISSA M PAUL
CHIEF DEVELOPMENT OFFICER	60.0	0.0			229495	0	36135		X
GLENN W BUNTING
VOICE & SPEECH CLINICAL DIR	60.0	0.0			178115	0	38210		X
GREGORY J DONNELLY
ADMIN DIR ANCILLARY SVS	60.0	0.0			176560	0	30597		X
PHILLIP C JOHNSON
DIR FINANCIAL OPERATIONS	60.0	0.0			189622	0	39519		X
PETER J CHINETTI
FORMER VP FINANCE	0.0	0.0			110893	0	225			X
ALEC CHELOFF
CHIEF INFORMATION OFFICER	60.0	0.0			187203	0	19628			X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	5273389	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	1563178	TotalReportableCompFrmRltdOrgs
Total Other Compensation	766820	TotalOtherCompensation
Number Individuals GT100 K	169	NumberIndividualsGT100K
Formers Listed	true	FormersListed
Total Comp GT150 K	true	TotalCompGT150K
Compensation From Other Sources	false	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
TSOIKOBUS ASSOCIATES
1 BRATTLE SQUARE PO BOX 9114	CAMBRIDGE	MA	02238	ARCHITECTS	529047
CG ASSOCIATES
7 CHUCK DRIVE	DRACUT	MA	01826	CONSTRUCTION	561339
FISH RICHARDSON PC
PO BOX 3295	BOSTON	MA	02241	LEGAL	419419
LFREP SERVICES LLP
260 FRANKLIN ST	BOSTON	MA	02110	CONSULTING SERVICES	285900
PRICEWATERHOUSECOOPERS
PO BOX 7247-8001	PHILADELPHIA	PA	19170	AUDIT	272079

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	5	NumberOfContractorsGT100K
Related Organizations	11585707	RelatedOrganizations
Government Grants	17262316	GovernmentGrants
All Other Contributions	10565461	AllOtherContributions
Total Contributions	39413484	TotalContributions

Program Service Revenue ProgramServiceRevenue (5 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome
INPATIENT AND OUTPATIENT	900099	144676161	144676161
MISCELLANEOUS REVENUE	900099	6368497	6368497
RESEARCH OVERHEAD	900099	6680683	6680683
HEARING AID CENTERS	900099	3711822	3711822
CAFETERIA/FOOD SERVICE	722210	1815212	1815212

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	1653000	TotalRevenueColumn
Related Or Exempt Function Income	1653000	RelatedOrExemptFunctionIncome

Field	Value	IRS element (for citing)
Total Program Service Revenue	164905375	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	91517	TotalRevenueColumn
Exclusion	$91,517	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	16279280	TotalRevenueColumn
Exclusion	$16,279,280	ExclusionAmount

Rental Income Or Loss RentalIncomeOrLoss

Field	Value	IRS element (for citing)
Real	0	Real
Personal	0	Personal

Net Rental Income Or Loss NetRentalIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	975972	Securities

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	975972	Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	975972	TotalRevenueColumn
Exclusion	$975,972	ExclusionAmount

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Net Income From Gaming NetIncomeFromGaming

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Net Income Or Loss NetIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Field	Value	IRS element (for citing)
Total Other Revenue	0	TotalOtherRevenue

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	221665628	TotalRevenueColumn
Related Or Exempt Function Income	164905375	RelatedOrExemptFunctionIncome
Exclusion	$17,346,769	ExclusionAmount

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	X	InfoInScheduleOPartIX

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	16535926	Total
Program Services	16535926	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	181635	Total
Program Services	181635	ProgramServices

Benefits To Members BenefitsToMembers

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	3391691	Total
Program Services	1088011	ProgramServices
Management And General	2303680	ManagementAndGeneral

Comp Disqual Persons CompDisqualPersons

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	80352122	Total
Program Services	60331408	ProgramServices
Management And General	18939317	ManagementAndGeneral
Fundraising	1081397	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	1518870	Total
Program Services	1120793	ProgramServices
Management And General	374686	ManagementAndGeneral
Fundraising	23391	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	15203484	Total
Program Services	11419588	ProgramServices
Management And General	3542826	ManagementAndGeneral
Fundraising	241070	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	6507253	Total
Program Services	4801786	ProgramServices
Management And General	1605256	ManagementAndGeneral
Fundraising	100211	Fundraising

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	881161	Total
Program Services	613336	ProgramServices
Management And General	267825	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	428765	Total
Program Services	166000	ProgramServices
Management And General	262765	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	212652	Total
Program Services	0	ProgramServices
Management And General	212652	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	278479	Total
Fundraising	278479	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	3509030	Total
Program Services	3273725	ProgramServices
Management And General	235305	ManagementAndGeneral
Fundraising	0	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	1094568	Total
Program Services	23120	ProgramServices
Management And General	1071448	ManagementAndGeneral
Fundraising	0	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	2042436	Total
Program Services	1069607	ProgramServices
Management And General	857921	ManagementAndGeneral
Fundraising	114908	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	2707950	Total
Program Services	0	ProgramServices
Management And General	2707950	ManagementAndGeneral
Fundraising	0	Fundraising

Royalties Royalties

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	9174698	Total
Program Services	944396	ProgramServices
Management And General	8230302	ManagementAndGeneral
Fundraising	0	Fundraising

Travel Travel

Field	Value	IRS element (for citing)
Total	909403	Total
Program Services	656187	ProgramServices
Management And General	209351	ManagementAndGeneral
Fundraising	43865	Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Interest Interest

Field	Value	IRS element (for citing)
Total	2038999	Total
Program Services	1415063	ProgramServices
Management And General	623936	ManagementAndGeneral

Payments To Affiliates PaymentsToAffiliates

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	18645562	Total
Program Services	12940000	ProgramServices
Management And General	5705562	ManagementAndGeneral
Fundraising	0	Fundraising

Insurance Insurance

Field	Value	IRS element (for citing)
Total	1114170	Total
Program Services	66652	ProgramServices
Management And General	1047518	ManagementAndGeneral
Fundraising	0	Fundraising

Other Expenses OtherExpenses (4 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
MEDICAL SUPPLIES	32239713	32140697	99016	0
PHYSICIANS ADMINISTRATION	5962667	5893359	69308	0
MISCELLANEOUS	8110779	5217525	2778335	114919
ALL OTHER EXPENSES	9702357	4124835	5555057	22465

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	222744370	Total
Program Services	164023649	ProgramServices
Management And General	56700016	ManagementAndGeneral
Fundraising	2020705	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	84562	BOY
EOY	1374003	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	20951960	BOY
EOY	21380084	EOY

Receivables From Officers Etc ReceivablesFromOfficersEtc

Field	Value	IRS element (for citing)
BOY	20000	BOY
EOY	10000	EOY

Receivables From Disqual Persons ReceivablesFromDisqualPersons

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Inventories For Sale Or Use InventoriesForSaleOrUse

Field	Value	IRS element (for citing)
BOY	2155473	BOY
EOY	2302498	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	3862909	BOY
EOY	4078975	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	375862839	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	237421178	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	133268256	BOY
EOY	138441661	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Intangible Assets IntangibleAssets

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	75836493	BOY
EOY	56462194	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	236179653	BOY
EOY	224049415	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	80079903	BOY
EOY	70433190	EOY

Grants Payable GrantsPayable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	37959380	BOY
EOY	25513725	EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

Field	Value	IRS element (for citing)
BOY	86480956	BOY
EOY	83647571	EOY

Escrow Account Liability EscrowAccountLiability

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Loans From Officers Directors LoansFromOfficersDirectors

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Unsecured Notes Loans Payable UnsecuredNotesLoansPayable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	5816094	BOY
EOY	7935144	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	210336333	BOY
EOY	187529630	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	25843320	BOY
EOY	36519785	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	25843320	BOY
EOY	36519785	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	236179653	BOY
EOY	224049415	EOY

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	X	InfoInScheduleOPartXI
Reconcilation Revenue Expenses	-1078742	ReconcilationRevenueExpenses
Reconciliation Unrealized Invest	-126562	ReconciliationUnrealizedInvest
Reconcilation Other Changes	11881769	ReconcilationOtherChanges
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	false	AccountantCompileOrReview
FS Audited	true	FSAudited

FS Audited Basis FSAuditedBasis

Field	Value	IRS element (for citing)
Financial Statement Consolidated	X	FinancialStatementConsolidated

Field	Value	IRS element (for citing)
Audit Committee	true	AuditCommittee
Federal Grant Audit Required	true	FederalGrantAuditRequired
Federal Grant Audit Performed	true	FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Hospital170b1 Aiii	X	Hospital170b1Aiii

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbying
Total Direct Lobbying		TotalDirectLobbying
Total Lobbying Expenditures		TotalLobbyingExpenditures
Other Exempt Purpose Expenditures		OtherExemptPurposeExpenditures
Total Exempt Purpose Expenditures		TotalExemptPurposeExpenditures
Lobbying Nontaxable		LobbyingNontaxableAmount
Grassroots Nontaxable		GrassrootsNontaxableAmount
Tot Lobbying Grassroot Minus Non Tx		TotLobbyingGrassrootMinusNonTx
Tot Lobby Expend Mns Lobbying Nontx		TotLobbyExpendMnsLobbyingNontx
Volunteers	false	Volunteers
Paid Staff Or Management	true	PaidStaffOrManagement
Media Advertisements	false	MediaAdvertisements
Mailings Members	true	MailingsMembers
Publications Or Broadcast	false	PublicationsOrBroadcast
Grants Other Organizations	false	GrantsOtherOrganizations
Direct Contact Legislators	true	DirectContactLegislators
Direct Contact Legislators	$212,652	DirectContactLegislatorsAmount
Rallies Demonstrations	false	RalliesDemonstrations
Other Activities	false	OtherActivities
Total Lobbying Expenditures IIB	212652	TotalLobbyingExpendituresIIB
Not Described In501c3	false	NotDescribedIn501c3

Form990 Schedule C Part IV Form990ScheduleCPartIV

Field	Value	IRS element (for citing)
Identifier	SCHEDULE C, PART II-B, LINE 1(I):	Identifier
Explanation	DURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2013, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") PAID A CONSULTANT TO ASSIST THE INFIRMARY ON BEHALF OF ITSELF AND ITS AFFILIATES, WITH DEVELOPING MEETINGS WITH THE MEMBERS OF THE MASSACHUSETTS LEGISLATURE AND EXECUTIVE BRANCH FOR PURPOSES OF DISCUSSION AROUND STATE HEALTHCARE PAYMENT REFORM, DISCUSSION AROUND MASSACHUSETTS EYE AND EAR REAL ESTATE DEVELOPMENT PLANNING, ASSIST IN PREPARING TESTIMONY FOR PRESENTATION BEFORE ALL RELEVANT COMMITTEES OF THE MASSACHUSETTS GENERAL COURT; DEVELOP LEGISLATIVE STRATEGIES; SERVE AS LIAISON TO GOVERNMENT AGENCIES AS NECESSARY AND MONITOR AND REPORT ON GOVERNMENT PROGRAMS RELATIVE TO HEALTHCARE FINANCING, INCLUDING STATE APPROPRIATIONS AND GRANTS. THE INFIRMARY IS A MEMBER OF CERTAIN TRADE ASSOCIATIONS THAT MAY LOBBY ON ITS BEHALF.	Explanation

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amts		ArtPublicExhibitionAmts
Held Works Of Art Amts		HeldWorksOfArtAmts
Collect Used For Public Exhibition	X	CollectUsedForPublicExhibition
Collect Used For Scholar Research	X	CollectUsedForScholarResearch
Collect Used For Preservation	X	CollectUsedForPreservation
Collect Used For Loan Or Exch Prgrms	X	CollectUsedForLoanOrExchPrgrms
Solicited Assets For Sale	false	SolicitedAssetsForSale

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	89724541	BeginningOfYearBalance
Contributions	2692680	Contributions
Investment Earnings Or Losses	3521682	InvestmentEarningsOrLosses
Other Expenditures	7238556	OtherExpenditures
Administrative Expenses	1495683	AdministrativeExpenses
End Of Year Balance	87204664	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	86399272	BeginningOfYearBalance
Contributions	1269332	Contributions
Investment Earnings Or Losses	6139492	InvestmentEarningsOrLosses
Other Expenditures	2803513	OtherExpenditures
Administrative Expenses	1280042	AdministrativeExpenses
End Of Year Balance	89724541	EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	60472244	BeginningOfYearBalance
Contributions	29640100	Contributions
Investment Earnings Or Losses	1622561	InvestmentEarningsOrLosses
Other Expenditures	4005052	OtherExpenditures
Administrative Expenses	1330581	AdministrativeExpenses
End Of Year Balance	86399272	EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	60355993	BeginningOfYearBalance
Contributions	736023	Contributions
Investment Earnings Or Losses	4138384	InvestmentEarningsOrLosses
Other Expenditures	3579845	OtherExpenditures
Administrative Expenses	1178311	AdministrativeExpenses
End Of Year Balance	60472244	EndOfYearBalance

Current Year Minus4 Years CurrentYearMinus4Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	60792309	BeginningOfYearBalance
Contributions	993556	Contributions
Investment Earnings Or Losses	3611396	InvestmentEarningsOrLosses
Other Expenditures	3713026	OtherExpenditures
Administrative Expenses	1328242	AdministrativeExpenses
End Of Year Balance	60355993	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.08553	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	0.59035	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.32411	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	false	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	true	EndowmentsHeldByRelatedOrgs
Are Related Orgs Listed Schedule R	true	AreRelatedOrgsListedScheduleR

Land Land

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	535324	OtherCostOrOtherBasis
Book Value	535324	BookValue

Buildings Buildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	176467311	OtherCostOrOtherBasis
Depreciation	106372037	Depreciation
Book Value	70095274	BookValue

Leasehold Improvements LeaseholdImprovements

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	15196635	OtherCostOrOtherBasis
Depreciation	1332442	Depreciation
Book Value	13864193	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	176275184	OtherCostOrOtherBasis
Depreciation	129661303	Depreciation
Book Value	46613881	BookValue

Other Land Buildings OtherLandBuildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	7388385	OtherCostOrOtherBasis
Depreciation	55396	Depreciation
Book Value	7332989	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	138441661	TotalOfBookValueLandBuildings

Other Assets OtherAssets (10 entries)

DescriptionDescription	Book ValueBookValue
DUE FROM AFFILIATES	29070759
FUNDS HELD FOR RESEARCH	3731041
CONSTRUCTION FUND	8751806
DEBT SERVICE FUND	174704
SPECIAL CASH & CAPITAL RESERVE	4163350
DEBT SERVICE RESERVES FUND	6042298
DEFERRED FINANCING COSTS	1540877
CAPITALIZED INTEREST	0
TAX DEFERRED PLAN	971900
CRICO	2015459

Field	Value	IRS element (for citing)
Total Book Value Other Assets	56462194	TotalBookValueOtherAssets
Federal Income Tax Liability	0	FederalIncomeTaxLiability

Other Liabilities OtherLiabilities (5 entries)

DescriptionDescription	AmountAmount
DUE TO AFFILIATES	$215,522
ESTIMATE THIRD PARTY SETTLEMEN	$4,218,998
PROFESSIONAL LIABILITY RESERVE	$2,528,724
ASSET RETIREMENT OBLIGATION	$0
TAX DEFERRED LIABILITY	$971,900

Field	Value	IRS element (for citing)
Total Of Amounts	7935144	TotalOfAmounts
Footnote In Part XIII	X	FootnoteInPartXIII

Form990 Schedule D Part XIII Form990ScheduleDPartXIII (2 entries)

IdentifierIdentifier

ExplanationExplanation

SCHEDULE D, PART III, LINE 4:

THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN EACH SPECIALTY OF THE EYE AND EAR AND BOOKS PURCHASED LATER WITH FUNDS FROM ENDOWMENTS SET UP BY THE PEOPLE WHO DONATED THE ORIGINAL COLLECTIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.

SCHEDULE D, PART X, LINE 2:

THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2013.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	true	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (9 entries)

RegionRegion	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
Europe (Including Iceland and Greenland)	Program Services	Research	127843
North America	Program Services	Research	53647
Central America and the Caribbean	Investments		24200
North America	Program Services	Conference	2557
South America	Program Services	Conference	1451
East Asia and the Pacific	Program Services	Conference	9832
Europe (Including Iceland and Greenland)	Program Services	Conference	74374
South Asia	Program Services	Conference	28982
Middle East and North Africa	Program Services	Conference	295

Field	Value	IRS element (for citing)
Subtotal Amount Spent	323181	SubtotalAmountSpent
Total Amount Spent	323181	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (2 entries)

RegionRegion	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Amount Of Non Cash AssistanceAmountOfNonCashAssistance
Europe (Including Iceland and Greenland)	127988	check	0
North America	53647	CHECK	0

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	false	TransferToForeignCorp
Interest In Foreign Trust	false	InterestInForeignTrust
Own Foreign Corp	true	OwnForeignCorp
Passive Foreign Invest Co	false	PassiveForeignInvestCo
Foreign Partnership	false	ForeignPartnership
Boycott Countries	false	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

Field	Value	IRS element (for citing)
Identifier	SCHEDULE F, PART I, LINE 2:	Identifier
Explanation	SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A STATISFACTORY PACE. SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1: THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER.	Explanation

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Agreement Ref Fundraising	true	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation (3 entries)

Name Of IndividualNameOfIndividual	ActivityActivity	Fundraiser Control Of FundsFundraiserControlOfFunds	Amount Retained By ContractorAmountRetainedByContractor
PURSUANT	ANNUAL FUND	false	85542
BRAKELEY BRISCO	CAPITAL CAMPAIGN	false	11291
VISION PHILANTHROPY GROUP	CAPITAL CAMPAIGN	false	130824

Field	Value	IRS element (for citing)
Total Retained By Contractors	227657	TotalRetainedByContractors
Licensed States	ME	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	NY	LicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

Field	Value	IRS element (for citing)
Identifier	SCHEDULE G, PART I, LINE 2B, COLUMN (V):	Identifier
Return Reference	DURING THE FISCAL YEAR ENDED SEPTEMBER 20, 2013, THE MASSACHUSETTS EYE	ReturnReference
Explanation	AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH PURSUANT, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PAITENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH BRAKELEY BRISCOE AND VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN.	Explanation

Schedule H IRS990ScheduleH

Field	Value	IRS element (for citing)
Charity Care Policy	true	CharityCarePolicy
Written Policy	true	WrittenPolicy
FPG Reference Free Care	true	FPGReferenceFreeCare

Other Percentage OtherPercentage

Field	Value	IRS element (for citing)
Other	X	Other
Free Other Percentage	400.	FreeOtherPercentage

Field	Value	IRS element (for citing)
FPG Reference Discounted Care	true	FPGReferenceDiscountedCare
Pcent400	X	Pcent400
Free Disc Care Medically Indigent	true	FreeDiscCareMedicallyIndigent
Amounts Budgeted For Charity Care	true	AmountsBudgetedForCharityCare
Expenses Exceeded Budget	true	ExpensesExceededBudget
Unable To Provide Care	false	UnableToProvideCare
Annual Community Benefit Report	true	AnnualCommunityBenefitReport
Report Publically Available	true	ReportPublicallyAvailable

Charity Care At Cost CharityCareAtCost

Field	Value	IRS element (for citing)
Total Community Benefit Expense	3500688	TotalCommunityBenefitExpense
Direct Offsetting Revenue	103938	DirectOffsettingRevenue
Net Community Benefit Expense	3396750	NetCommunityBenefitExpense
Percent Of Total Expense	0.01520	PercentOfTotalExpense

Unreimbursed Medicaid UnreimbursedMedicaid

Field	Value	IRS element (for citing)
Total Community Benefit Expense	13547737	TotalCommunityBenefitExpense
Direct Offsetting Revenue	11201367	DirectOffsettingRevenue
Net Community Benefit Expense	2346370	NetCommunityBenefitExpense
Percent Of Total Expense	0.01050	PercentOfTotalExpense

Unreimbursed Costs UnreimbursedCosts

Field	Value	IRS element (for citing)
Total Community Benefit Expense	3861948	TotalCommunityBenefitExpense
Direct Offsetting Revenue	3775107	DirectOffsettingRevenue
Net Community Benefit Expense	86841	NetCommunityBenefitExpense
Percent Of Total Expense	0.00040	PercentOfTotalExpense

Total Charity Care TotalCharityCare

Field	Value	IRS element (for citing)
Total Community Benefit Expense	20910373	TotalCommunityBenefitExpense
Direct Offsetting Revenue	15080412	DirectOffsettingRevenue
Net Community Benefit Expense	5829961	NetCommunityBenefitExpense
Percent Of Total Expense	0.02610	PercentOfTotalExpense

Community Health Services CommunityHealthServices

Field	Value	IRS element (for citing)
Total Community Benefit Expense	452931	TotalCommunityBenefitExpense
Direct Offsetting Revenue	0	DirectOffsettingRevenue
Net Community Benefit Expense	452931	NetCommunityBenefitExpense
Percent Of Total Expense	0.00200	PercentOfTotalExpense

Health Professions Education HealthProfessionsEducation

Field	Value	IRS element (for citing)
Total Community Benefit Expense	7136496	TotalCommunityBenefitExpense
Direct Offsetting Revenue	1450476	DirectOffsettingRevenue
Net Community Benefit Expense	5686020	NetCommunityBenefitExpense
Percent Of Total Expense	0.02550	PercentOfTotalExpense

Subsidized Health Services SubsidizedHealthServices

Field	Value	IRS element (for citing)
Number Of Activities Or Programs	2	NumberOfActivitiesOrPrograms
Persons Served	624	PersonsServed
Total Community Benefit Expense	1907390	TotalCommunityBenefitExpense
Direct Offsetting Revenue	1504778	DirectOffsettingRevenue
Net Community Benefit Expense	402613	NetCommunityBenefitExpense
Percent Of Total Expense	0.00180	PercentOfTotalExpense

Research Research

Field	Value	IRS element (for citing)
Total Community Benefit Expense	38753403	TotalCommunityBenefitExpense
Direct Offsetting Revenue	946746	DirectOffsettingRevenue
Net Community Benefit Expense	37806657	NetCommunityBenefitExpense
Percent Of Total Expense	0.16970	PercentOfTotalExpense

Cash And In Kind Contributions CashAndInKindContributions

Field	Value	IRS element (for citing)
Total Community Benefit Expense	0	TotalCommunityBenefitExpense
Direct Offsetting Revenue	0	DirectOffsettingRevenue
Net Community Benefit Expense	0	NetCommunityBenefitExpense
Percent Of Total Expense	0.00000	PercentOfTotalExpense

Total Other Benefits TotalOtherBenefits

Field	Value	IRS element (for citing)
Number Of Activities Or Programs	2	NumberOfActivitiesOrPrograms
Persons Served	624	PersonsServed
Total Community Benefit Expense	48250220	TotalCommunityBenefitExpense
Direct Offsetting Revenue	3902000	DirectOffsettingRevenue
Net Community Benefit Expense	44348221	NetCommunityBenefitExpense
Percent Of Total Expense	0.19900	PercentOfTotalExpense

Total Community Benefits TotalCommunityBenefits

Field	Value	IRS element (for citing)
Number Of Activities Or Programs	2	NumberOfActivitiesOrPrograms
Persons Served	624	PersonsServed
Total Community Benefit Expense	69160593	TotalCommunityBenefitExpense
Direct Offsetting Revenue	18982412	DirectOffsettingRevenue
Net Community Benefit Expense	50178182	NetCommunityBenefitExpense
Percent Of Total Expense	0.22510	PercentOfTotalExpense

Field	Value	IRS element (for citing)
Bad Debt Expense Reported	true	BadDebtExpenseReported
Bad Debt Expense	$2,681,043	BadDebtExpenseAmount
Amount Attributable To	9648	AmountAttributableTo
Amount Reimbursed By Medicare	39144941	AmountReimbursedByMedicare
Cost Of Care Reimbursed By Medicare	43530661	CostOfCareReimbursedByMedicare
Medicare Surplus Or Shortfall	-4385720	MedicareSurplusOrShortfall

Costing Methodology Used CostingMethodologyUsed

Field	Value	IRS element (for citing)
Cost Accounting System	X	CostAccountingSystem

Field	Value	IRS element (for citing)
Written Debt Collection Policy	true	WrittenDebtCollectionPolicy
Provision For Charity Care	true	ProvisionForCharityCare
Number Of Hospital Facilities	1	NumberOfHospitalFacilities

Form990 Schedule H Part V Section A Form990ScheduleHPartVSectionA

Field	Value	IRS element (for citing)
Facility Number	1	FacilityNumber

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	MASSACHUSETTS EYE & EAR INFIRMARY	BusinessNameLine1

Address Address

Field	Value	IRS element (for citing)
Address Line1	243 CHARLES STREET	AddressLine1
City	BOSTON	City
State	MA	State
ZIP Code	02114	ZIPCode

Field	Value	IRS element (for citing)
Website Address	http://www.masseyeandear.org/	WebsiteAddress
Licensed Hospital	X	LicensedHospital
Teaching Hospital	X	TeachingHospital
Research Facility	X	ResearchFacility
Er24 Hours	X	Er24Hours

Form990 Schedule H Part V Section B Form990ScheduleHPartVSectionB

Hospital Facility Name HospitalFacilityName

Field	Value	IRS element (for citing)
Business Name Line1	MASSACHUSETTS EYE & EAR INFIRMARY	BusinessNameLine1

Field	Value	IRS element (for citing)
CHNA Conducted	true	CHNAConducted
Community Definition	X	CommunityDefinition
Community Demographics	X	CommunityDemographics
How Data Obtained	X	HowDataObtained
Community Health Needs	X	CommunityHealthNeeds
Other Health Issues	X	OtherHealthIssues
Identifying Process	X	IdentifyingProcess
Consulting Process	X	ConsultingProcess
Information Gaps	X	InformationGaps
Needs Assessment Conducted	13	NeedsAssessmentConducted
Take Into Account	true	TakeIntoAccount
Other Facilities	false	OtherFacilities
Own Website	X	OwnWebsite
On Request	X	OnRequest
Adopt Implement Strategy	X	AdoptImplementStrategy
Execute Implement Strategy	X	ExecuteImplementStrategy
Develop Community Plan	X	DevelopCommunityPlan
Participate Community Plan	X	ParticipateCommunityPlan
Include Operational Plans	X	IncludeOperationalPlans
Adopt Budget	X	AdoptBudget
Prioritize Health Needs	X	PrioritizeHealthNeeds
Prioritize Services	X	PrioritizeServices
All Needs Addressed	false	AllNeedsAddressed
Organization Incur Excise Tax	false	OrganizationIncurExciseTax
Eligibility Criteria Explained	true	EligibilityCriteriaExplained
Uses FPG Free	true	UsesFPGFree
FPG Free Percent	400.	FPGFreePercent
Uses FPG Discounted	true	UsesFPGDiscounted
FPG Discount Percent	400.	FPGDiscountPercent
Explains Basis	true	ExplainsBasis
Income Level	X	IncomeLevel
Asset Level	X	AssetLevel
Medical Indigency	X	MedicalIndigency
Insurance Status	X	InsuranceStatus
Uninsured Discount	X	UninsuredDiscount
Medicaid Medicare	X	MedicaidMedicare
State Regulation	X	StateRegulation
Explains Application Method	true	ExplainsApplicationMethod
Includes Publicity Measures	true	IncludesPublicityMeasures
Posted On Website	X	PostedOnWebsite
Attached To Invoices	X	AttachedToInvoices
Posted In Emergency Room	X	PostedInEmergencyRoom
Posted In Admission Office	X	PostedInAdmissionOffice
Provided On Admission	X	ProvidedOnAdmission
Available On Request	X	AvailableOnRequest
Actions On Nonpayment	true	ActionsOnNonpayment
Collection Activities	false	CollectionActivities
Nondiscrim Emergency Care Policy	true	NondiscrimEmergencyCarePolicy
Used Other Method	X	UsedOtherMethod
Amounts Generally Billed	false	AmountsGenerallyBilled
Gross Charges	false	GrossCharges

Form990 Schedule H Part V Section C Form990ScheduleHPartVSectionC

Field	Value	IRS element (for citing)
Number Of Other Facilities	7	NumberOfOtherFacilities

Other Facilities OtherFacilities (7 entries)

Address Line1Address/AddressLine1	CityAddress/City	StateAddress/State	ZIP CodeAddress/ZIPCode	Facility TypeFacilityType
MASSACHUSETTS EYE & EAR STONEHAM
ONE MONTVALE AVENUE	STONEHAM	MA	02180	LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR E BRIDGEWATER
ONE COMPASS WAY SUITE 100	E BRIDGEWATER	MA	02333	LICENSED OUTPATIENT LOCATION
MEEI VESTIBULAR CENTER AT BRAINTREE
250 POND STREET 1ST FLOOR	BRAINTREE	MA	02184	LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR QUINCY
500 CONGRESS STREET	QUINCY	MA	02169	LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR AT JOSLIN
1 JOSLIN PLACE	BOSTON	MA	02215	LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR CONCORD
54 BAKER AVE EXTENSION 3RD FL STE	CONCORD	MA	01742	LICENSED OUTPATIENT LOCATION
MASSACHUSETTS EYE & EAR LONGWOOD
800 HUNTINGTON AVENUE	BOSTON	MA	02115	LICENSED OUTPATIENT LOCATION

Form990 Schedule H Part VI Form990ScheduleHPartVI (16 entries)

IdentifierIdentifier	ExplanationExplanation
SCHEDULE H, PART II:	THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND IT'S AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 16 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS.
SCHEDULE H, PART III, LINE 4:	BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT.
SCHEDULE H, PART III, LINE 8:	THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER.
SCHEDULE H, PART III, LINE 9B:	PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE.
Schedule H, Part V, Section B, Line 3:	To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 5A: The community health needs assessment can be found online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 40 young adults receive exams through vision coalition. -At least 50 people will receive support for and education about glaucoma. Only 43 people received education from annual glaucoma support group before group disbanded during the fiscal year. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least one individual will receive reconstructive surgery to address injuries caused by domestic violence. Hospital did not receive any referrals from the R.O.S.E. in FY13. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 45 people were screen at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS.
SCHEDULE H, PART VI, LINE 2:	MEEI ENGAGED THE SERVICES OF CONSULTANTS TO WORK CLOSELY WITH THE COMMUNITY BENEFITS (BC) WORKING GROUP THROUGHOUT THE ASSESSMENT AND PLANNING PROCESS, WHICH TOOK PLACE DURING THE FALL 2012/WINTER 2013. DURING THE ASSESSMENT AND PLANNING PROCESSES, THE CB WORKING GROUP MET REGULARLY AND ENGAGED THE FULL COMMITTEE AS NEEDED FOR PROGRESS UPDATES AND INPUT. AFTER THE PLAN WAS DEVELOPED AND APPROVED, MEETINGS DECREASED IN FREQUENCY AND THE GROUPS MET ON AN AS-NEEDED BASIS. FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILALBE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MEEI'S CB COMMITTEE HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN.
SCHEDULE H, PART VI, LINE 3:	MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A LINK WHICH HIGHLIGHTS THE BASIC FEDERAL PROGRAMS AND ACCESS TO MEEI'S FINANCIAL COUNSELORS. THE FINANCIAL COUNSELING PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED.
SCHEDULE H, PART VI, LINE 4:	STEP 1: IDENTIFY MEEI'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MEEI COMMUNITY BENEFIT PLANS BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2011 THROUGH MARCH 31, 2012) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 65,429 PATIENTS. BELOW, OBSERVATIONS ABOUT PATIENTS' SEX, RACE/ETHNICITY, AGE, SOCIO-ECONOMIC STATUS, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. DEMOGRAPHIC CATEGORIES & STATISTICS: SEX: OVER HALF (53.4%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 75% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT THE HOSPITAL. FIGURE 1 BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (60.2%) ARE WHITE. RACIAL/ETHNIC BREAKDOWN: (NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS) AMERICAN INDIAN/ALASKA NATIVE: 125; 0.2% ASIAN: 2,196; 3.4% BLACK/AFRICAN AMERICAN: 4,684; 7.2% HISPANIC: 1,090; 1.7% PACIFIC ISLANDER: 25; <1% WHITE: 39,392; 60.2% OTHER: 1,148; 1.7% UNKNOWN: 16,769; 25.6% TOTAL: 65,429; 100% BECAUSE THERE IS SO MUCH MISSING INFORMATION ABOUT RACE/ETHNICITY, THE DATA WERE NOT PARTICULARLY USEFUL IN IDENTIFYING VULNERABLE POPULATIONS. GEOGRAPHY: NOTE THAT WITHIN DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTON'S 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 11 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 11 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MEEI PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MEEI PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. OF THE 65,429 MASSACHUSETTS PATIENTS IN THE DATA SET, NEARLY 30% LIVE IN BOSTON AND NEARLY HALF (49.2%) LIVE IN COMMUNITIES INSIDE ROUTE 128 (INCLUDING BOSTON). THE VAST MAJORITY (82.8%) OF PATIENTS ARE FROM COMMUNITIES INSIDE OF ROUTE 495. PERCENT OF MEEI PATIENTS LIVING IN GEOGRAPHIC AREAS OF MASSACHUSETTS: BOSTON/BOSTON NEIGHBORHOODS: 29.5% WITHIN 128 (EXCEPT BOSTON): 19.7% NORTH SHORE: 3.2% INSIDE 495 (BEYOND 128): 30.4% OUTSIDE 495 - CENTRAL: 6.6% OUTSIDE 495 - NORTH: 4.5% WESTERN MA: 5.1% CAPE/ISLANDS: <1% TO IDENTIFY POPULATION CENTERS, THE CONSULTANTS LOOKED FOR THE COMMUNITIES/NEIGHBORHOODS IN WHICH THE LARGEST NUMBERS OF MEEI PATIENTS LIVE. FIFTEEN COMMUNITIES/NEIGHBORHOODS ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS. NEARLY HALF (49.9%) LIVE IN THESE 15 COMMUNITIES. MASSACHUSETTS COMMUNITIES/NEIGHBORHOODS WITH HIGHEST PROPORTION OF MEEI PATIENTS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS; GEOGRAPHIC AREA) BOSTON (NO COMMUNITY SPECIFIED): 12,575; 19.2%; BOSTON JAMAICA PLAIN: 1,007; 1.5%; BOSTON WEST ROXBURY: 817; 1.2%; BOSTON ROSLINDALE: 789; 1.2%; BOSTON HYDE PARK: 780; 1.2%; BOSTON ALLSTON/BRIGHTON: 1,414; 2.2%; BOSTON CHARLESTOWN: 1,188; 1.8%; BOSTON CAMBRIDGE: 4,037; 6.2%; WITHIN 128 LYNN: 3,941; 6.0%; WITHIN 128 WAKEFIELD: 911; 1.4%; WITHIN 128 WOBURN: 933; 1.4%; WITHIN 128 READING/N. READING: 1,180; 1.8%; INSIDE 495 ANDOVER/N. ANDOVER: 1,356; 2.1%; INSIDE 495 FRAMINGHAM: 941; 1.4%; INSIDE 495 WORCESTER: 752; 1.1%; OUTSIDE 495 AGE: THE MASSACHUSETTS ATTORNEY GENERAL IS INTERESTED IN HAVING THE HOSPITAL COMMUNITY BENEFITS PLANS TARGET VULNERABLE POPULATIONS. MEEI HAS CLINICAL EXPERTISE IN SERVING ELDERS AND CHILDREN, POTENTIALLY VULNERABLE POPULATIONS SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MEEI'S COMMUNITY BENEFITS PLAN BECAUSE OF THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. THE MEAN AGE OF MEEI PATIENTS IS 46.81 YEARS, WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 106 YEARS OF AGE. PATIENTS AGED 65 AND OVER MAKE UP 23.5% OF THOSE SEEN DURING THE SELECTED TIMEFRAME, WHEREAS THOSE 18 OR YOUNGER CONSTITUTE 13.7% OF THE POPULATION. BELOW SHOWS THE PROPORTION OF PATIENTS IN VARIOUS AGE GROUPS: (AGE GROUP: PERCENTAGE OF TOTAL) <1 YEAR TO 18 YEARS OLD: 13.7% 19 TO 24 YEARS OLD: 5.4% 25 TO 34 YEARS OLD: 10.6% 35 TO 44 YEARS OLD: 12.2% 45 TO 54 YEARS OLD: 16.3% 55 TO 64 YEARS OLD: 18.3% 65 AND OVER: 23.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBER OF MEEI'S SENIOR (65 YEARS AND OLDER) POPULATION. THESE TEN COMMUNITIES ARE HOME TO 34% OF MEEI SENIORS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,820; 11.8% CAMBRIDGE: 1,015; 6.6% DORCHESTER: 540; 3.5% LYNN: 386; 2.5% BRIGHTON: 298; 1.9% FRAMINGHAM: 261; 1.7% JAMAICA PLAIN: 238; 1.5% PEABODY: 237; 1.5% SAUGUS: 227; 1.5% WOBURN: 227; 1.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO ARE LESS THAN 1 YEAR OF AGE THROUGH AGE 18. NEARLY 30% OF THE CHILDREN SERVED BY MEEI DURING THE DESIGNATED TIME PERIOD LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 883; 9.9% LYNN: 370; 4.1% CAMBRIDGE: 350; 3.9% SAUGUS: 192; 2.1% CHARLESTOWN: 175; 2.0% WOBURN: 169; 1.9% HAVERHILL: 143; 1.6% ANDOVER: 141; 1.6% DORCHESTER: 131; 1.4% READING: 129; 1.4% SOCIO-ECONOMIC STATUS: SOCIO-ECONOMIC (SES) IS ANOTHER VARIABLE ASSOCIATED WITH VULNERABLE POPULATIONS. PATIENTS' HEALTH INSURANCE CAN BE USED AS A PROXY FOR SES BECAUSE THERE ARE INCOME ELIGIBILITY REQUIREMENTS IN PLACE FOR PUBLIC PAYERS THAT ALLOW US TO MAKE ASSUMPTIONS ABOUT WHICH PATIENTS ARE LOW INCOME. IT IS IMPORTANT TO NOTE THAT THE NUMBER OF LOW-INCOME PATIENTS SERVED BY MEEI IS LIKELY MUCH HIGHER. IT IS NOT POSSIBLE TO KNOW HOW MANY MASSHEALTH PATIENTS, FOR EXAMPLE, ARE INSURED THROUGH A COMMERCIAL CARRIER WITH A MANAGED CARE CONTRACT WITH MASSHEALTH. ADDITIONALLY, IT IS NOT POSSIBLE TO KNOW WHICH PORTION OF THE SENIORS USING MEDICARE PRODUCTS TO PAY FOR THE SERVICES THEY RECEIVE AT MEEI ARE LOW-INCOME AND WHICH ARE NOT. ALTHOUGH AN IMPERFECT METHOD FOR DETERMINING THE SES OF PATIENTS, THESE ARE THE BEST DATA AVAILABLE FOR THIS PURPOSE. USING PAYER AS PROXY, IT APPEARS THAT JUST OVER 11% OF THE MEEI PATIENTS ARE LOW-INCOME, BROKEN DOWN AS FOLLOWS:
(PUBLIC PAYER: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL)	MASSHEALTH: 3,672; 7.1% HEALTH SAFETY NET: 796; 1.2% MEDICAID: 287; 0.4% BMC HEALTH NET: 143; 0.2% NETWORK HEALTH: 1,493; 2.3% THE AVERAGE AGE OF THESE LOW-INCOME PATIENTS IS 37 WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 96 YEARS OF AGE. IT IS IMPORTANT TO NOTE THAT THE VAST MAJORITY OF SENIORS (65+) ARE EXCLUDED FROM THE ANALYSES BECAUSE MOST SENIORS USE MEDICARE PRODUCTS TO PAY FOR THEIR CARE. TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO HAVE LOW SES. NEARLY 50% OF THE PATIENTS WITH LOW SES LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,102; 17.2% LYNN: 504; 7.9% CAMBRIDGE: 440; 6.9% DORCHESTER: 248; 3.8% LAWRENCE: 198; 3.1% CHARLESTOWN: 160; 2.5% EAST BOSTON: 163; 2.2% SAUGUS: 129; 2.0% LOWELL: 127; 2.0% WORCESTER: 123; 1.9% MEEI SERVES A POPULATION WITH A LARGE AGE RANGE, INCLUDING SIGNIFICANT SENIOR (65+) AND PEDIATRIC (LESS THAN ONE YEAR THROUGH AGE 18) POPULATIONS. USING PATIENT PAYER AS A PROXY FOR SES, AT LEAST 11.2% OF THE PATIENTS HAVE LOW SES. NEARLY HALF OF MEEI'S PATIENTS LIVE IN COMMUNITIES WITHIN ROUTE 128, INCLUDING BOSTON AND SELECT NEIGHBORHOODS. ELEVEN OF THE 15 COMMUNITIES THAT ARE HOME TO THE LARGEST CONCENTRATION OF MEEI PATIENTS ARE WITHIN THIS GEOGRAPHIC AREA. THERE IS OVERLAP IN THE TOP COMMUNITIES FOR THE GENERAL POPULATION OF PATIENTS SEEN DURING THE DESIGNATED TIMEFRAME AND THE VULNERABLE POPULATIONS. THREE ARE AMONG THE TOP COMMUNITIES FOR THE OVERALL POPULATION AND ELDERS, CHILDREN AND THOSE WITH LOW-SES: BOSTON, CAMBRIDGE AND LYNN. TWO OTHERS (DORCHESTER AND SAUGUS) ARE AMONG THE TOP TEN FOR ALL THREE VULNERABLE GROUPS. IT MAY BE POSSIBLE TO MAXIMIZE RESOURCES FOR ADDRESSING THE NEEDS OF PATIENTS OVERALL AND AMONG THE VULNERABLE POPULATIONS BY CONCENTRATING EFFORTS IN COMMUNITIES/NEIGHBORHOODS WITHIN 128, ESPECIALLY THOSE WHERE SUCH OVERLAPS EXIST. A 2010 CENSUS MAP PRODUCED BY THE BOSTON GLOBE AND AVAILABLE ON-LINE SHOWS THAT THE LARGEST CONCENTRATION OF PEOPLE OF COLOR IN MASSACHUSETTS IS IN THE METRO BOSTON AREA. A SIMILAR 2010 CENSUS MAP SHOWS THAT, ALTHOUGH METRO BOSTON IS HOME TO SOME OF THE COMMONWEALTH'S WEALTHIEST COMMUNITIES, IT IS ALSO HOME TO SOME OF THE LOWEST INCOME COMMUNITIES. A THIRD MAP CREATED BY THE GERONTOLOGY INSTITUTE AT THE MCCORMACK GRADUATE SCHOOL OF POLICY AND GLOBAL STUDIES AT THE UNIVERSITY OF MASSACHUSETTS BOSTON SHOWS THAT THE POPULATION OF SENIORS LIVING WITHIN THE METRO BOSTON AREA EXCEEDS THE STATEWIDE AVERAGE. ACCORDING TO THE 2010 CENSUS, 13.8% OF MASSACHUSETTS RESIDENTS ARE AGED 65 AND OLDER. WITHIN THE MAJORITY OF METRO BOSTON COMMUNITIES, SENIORS COMPRISE BETWEEN 15.1% AND 20% OF THE CITY/TOWN POPULATIONS. CONCLUSIONS: BASED ON THE MOST RECENT CENSUS DATA AND MEEI'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MEEI CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITAL'S PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES IN THE METRO-BOSTON AREA (WITHIN THE ROUTE 128 BELT). ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF VULNERABLE (I.E., CHILDREN, ELDERLY AND LOW-INCOME) PATIENTS RESIDE WITHIN THE METRO-BOSTON/128 AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MEEI'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. BECAUSE OF THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS PARTICULARLY VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MEEI SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN.
STEP 2: ASSESS UNMET NEEDS IN METRO BOSTON AND AMONG THE TARGET	POPULATIONS THE CB WORKING GROUP, OTHER MEMBERS OF THE COMMUNITY BENEFITS COMMITTEE, OTHER PROVIDERS AND STAFF AT MEEI, AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES WORKED TOGETHER TO UNDERSTAND THE UNMET NEEDS THAT, AS AN INSTITUTION, MEEI IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE SUMMER AND FALL OF 2012, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE CONSISTENT WITH THOSE IDENTIFIED IN THE 2010 COMMUNITY BENEFITS PLAN: -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF DOMESTIC VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK AS A RESULT OF ABUSE. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MEEI SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF COMMUNITY-BASED NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN POVERTY OVER THE LAST SEVERAL YEARS, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MEEI WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF MEEI AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. STEP 3: ASSESS NEEDS IN MISSION HILL AS NOTED EARLIER, MEEI DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN MISSION HILL, THE NEIGHBORHOOD IN WHICH ITS NEW OUT-PATIENT FACILITY IS LOCATED. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. JUST OVER 44% OF RESIDENTS SPEAK A LANGUAGE OTHER THAN OR IN ADDITION TO ENGLISH. OF THOSE WHO SPEAK A LANGUAGE OTHER THAN ENGLISH, 33.2% ARE LINGUISTICALLY ISOLATED BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER-OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH, HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME FAMILIES. SENIORS AND CHILDREN MAKE UP ROUGHLY 30% OF THE MISSION HILL POPULATION. TO LEARN ABOUT MEEI'S PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MEEI CARED FOR 263 PATIENTS WHO LIVE IN MISSION HILL (1.6% OF THE MISSION HILL POPULATION). WITH THE NEW FACILITY IN MISSION HILL AND A CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THAT NUMBER TO RISE OVER THE NEXT THREE YEARS. (SEE FIGURE 11 IN THE OFFICIAL MEEI COMMUNITY BENEFITS REPORT FOR THE DEMOGRAPHICS OF MEEI'S PATIENTS WHO LIVE IN MISSION HILL.) AFTER PROFILING THE DEMOGRAPHICS OF THE NEIGHBORHOOD, THE CONSULTANTS INTERVIEWED TWO SENIOR MANAGERS FOR COMMUNITY BENEFITS AT BRIGHAM AND WOMEN'S HOSPITAL (BWH). BWH IS LOCATED IN THE LONGWOOD MEDICAL AREA, NEIGHBORING MISSION HILL, AND HAS AN EXTENSIVE COMMUNITY BENEFITS PROGRAM THAT INVOLVES NUMEROUS INITIATIVES IN THE MISSION HILL. BOTH SENIOR MANAGERS HAVE SIGNIFICANT EXPERIENCE WORKING IN MISSION HILL AND WERE ABLE TO PROVIDE AN OVERVIEW OF BWH'S EXPERIENCE IN THE NEIGHBORHOOD. BOTH SENIOR MANAGERS SHARED A SYNOPSIS OF FINDINGS FROM THEIR OWN COMMUNITY BENEFITS NEEDS ASSESSMENT IN MISSION HILL. TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MEEI CB WORKING GROUP AND WITH BRIGHAM AND WOMEN'S HOSPITAL COMMUNITY BENEFITS LEADERS TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. THE INTERVIEW DATA WERE ANALYZED FOR COMMON AND DIVERGENT THEMES, WHICH ARE SUMMARIZED BELOW. MISSION HILL WAS DESCRIBED AS A COMMUNITY OF HIGH ECONOMIC NEED AND ONE IN WHICH JOB CREATION, JOB TRAINING, AND YOUTH EMPLOYMENT ARE HIGH PRIORITIES. THE KEY INFORMANTS DESCRIBED MISSION HILL RESIDENTS AS CULTURALLY AND LINGUISTICALLY DIVERSE WITH LARGE POPULATIONS OF HISPANIC, CHINESE, RUSSIAN, SOMALI, AND ETHIOPIAN RESIDENTS. THE COMMUNITY IS ALSO HOME TO A NUMBER OF HIGHLY DEDICATED ADVOCATES WHO ARE DEEPLY COMMITTED TO WORKING WITH INSTITUTIONAL NEIGHBORS TO BENEFIT THE NEIGHBORHOOD AND TO RESOLVE ISSUES AS THEY ARISE. MEEI IS VIEWED IN A POSITIVE LIGHT AND WAS OVERWHELMINGLY WELCOMED TO THE NEIGHBORHOOD. ALL OF THE KEY INFORMANTS EXPRESSED A SINCERE DESIRE TO HELP MEEI AS THE HOSPITAL BECOMES FAMILIAR WITH THE COMMUNITY AND INTRODUCES COMMUNITY BENEFITS PROGRAMS.
MISSION HILL RESIDENTS ACCESS ROUTINE HEALTH CARE SERVICES FROM MANY	SOURCES, INCLUDING THE LOCAL HOSPITAL PRIMARY CARE PRACTICES, COMMUNITY HEALTH CENTERS AND HOSPITAL EMERGENCY ROOMS. DIABETES WAS IDENTIFIED AS A PARTICULAR HEALTH ISSUE OF CONCERN IN MISSION HILL. THE KEY INFORMANTS REPORTED THAT VISION AND HEARING ISSUES ARE NOT ADDRESSED IN A COMPREHENSIVE MANNER IN THE COMMUNITY AND THAT A NEED FOR SUCH CARE EXISTS. THE KEYS TO BUILDING AND SUSTAINING STRONGLY RELATIONSHIPS IN THE COMMUNITY WERE DESCRIBED AS: -BEING A GOOD AND RESPECTFUL NEIGHBOR TO THOSE WHO ABUT THE NEW MEEI FACILITY, INCLUDING HAVING REGULAR DIALOGUE WITH THEM. -HAVING A PRESENCE IN MISSION HILL BY ATTENDING EVENTS. -HAVING A POINT PERSON/LIAISON TO THE NEIGHBORHOOD BEING RESPONSIVE AS NEEDS OR ISSUES ARISE -BEING INCLUSIVE, WORKING TO SERVE THE BROADER COMMUNITY RATHER THAN SPECIFIC ORGANIZATIONS WITHIN IT. -TAKING ADVANTAGE OF OPPORTUNITIES TO PARTNER WITH ORGANIZATIONS AND ADVOCATES IN MISSION HILL, INCLUDING MIKE ROSS, BOSTON CITY COUNCILMAN, WHO LIVES IN MISSION HILL. THE KEY INFORMANTS IDENTIFIED A NUMBER OF NEEDS THAT ARE CONSISTENT WITH MEEI'S CLINICAL EXPERTISE AND COMMUNITY BENEFITS MISSION, INCLUDING: -VISION/HEARING SCREENINGS FOR SENIORS AND FOR CHILDREN (TO COMPLEMENT SCREENINGS OFFERED BY THE BOSTON PUBLIC SCHOOLS) -FOLLOW UP CARE FOR SENIORS AND CHILDREN, INCLUDING FREE/REDUCED COST EYE GLASSES AND HEARING AIDS -EDUCATIONAL PROGRAMS/MATERIALS: -SENIORS: VISION CARE, ESPECIALLY RELATED TO DIABETES, BALANCE/FALLS PREVENTION, HEAD AND NECK ISSUES -YOUTH: HEARING ISSUES RELATED TO PORTABLE DEVICES AND HEADPHONES -TEACHERS: DETECTING HEARING AND VISION ISSUES AMONG STUDENTS AND THE RELATIONSHIP BETWEEN HEARING AND SPEECH. THE INTERVIEW PARTICIPANTS ALSO TALKED ABOUT THE NEED FOR ADDITIONAL JOB TRAINING/EMPLOYMENT OPPORTUNITIES, PARTICULARLY FOR YOUTH. SUGGESTIONS INCLUDED SUMMER JOBS FOR YOUTH, PAID INTERNSHIPS FOR YOUNG PEOPLE, EMPLOYMENT FOR MISSION HILL RESIDENTS AT THE MEEI MAIN CAMPUS AND THE MISSION HILL LOCATION, AND SCHOLARSHIP CONTRIBUTIONS. THE KEY INFORMANTS RECOMMENDED THAT MEEI "PIGGY BACK" ON EXISTING EFFORTS IN MISSION HILL TO REACH THE TARGET POPULATION FOR COMMUNITY BENEFITS INITIATIVES, GOING TO THE PLACE WHERE YOUTH AND SENIORS ALREADY TEND TO MEET (E.G., THE TOBIN COMMUNITY CENTER). THEY ALSO RECOMMENDED WORKING WITH ORGANIZATIONS THAT REPRESENT SENIORS AND CHILDREN FROM ACROSS MISSION HILL (E.G., THE LEGACY PROJECT, THE MISSION HILL YOUTH COLLABORATIVE) TO REACH THE MAXIMUM NUMBER OF YOUNG PEOPLE AND ELDERS IN THE COMMUNITY. THE ORGANIZATIONS IN MISSION HILL HAVE WELL-ESTABLISHED METHODS FOR COMMUNICATING WITH ONE ANOTHER AND WITH RESIDENTS ABOUT EVENTS IN THE COMMUNITY. ALTHOUGH SEVERAL USE EMAIL TO COMMUNICATE WITH THEIR COLLEAGUES IN OTHER ORGANIZATIONS, MOST ALSO DISSEMINATE FLYERS IN THE COMMUNITY TO ADVERTISE PROGRAMMING TO RESIDENTS. SOME ALSO USE PHONE TREES AND GO DOOR TO DOOR. NEWSLETTERS, CALENDARS, MONTHLY ORGANIZATION MEETINGS, AND THE LOCAL NEWSPAPER, THE MISSION HILL GAZETTE, ARE OTHER METHODS FOR SPREADING THE WORD IN MISSION HILL. ALL OF THE KEY INFORMANTS OFFERED TO HELP MEEI PUBLICIZE ITS COMMUNITY BENEFITS OFFERINGS THROUGH THEIR ESTABLISHED LINES OF COMMUNICATION. CONCLUSIONS: BASED ON THE FINDINGS FROM THE NEEDS ASSESSMENT IN MISSION HILL, THE COMMUNITY BENEFITS COMMITTEE DECIDED THAT IN EACH OF THE NEXT THREE YEARS, THE HOSPITAL'S COMMUNITY BENEFITS STRATEGIES IN THE NEIGHBORHOOD WILL INCLUDE THE FOLLOWING: -WORKING WITH THE MISSION HILL LEGACY PROJECT, OFFER A FREE VISION SCREENING TO AT LEAST 25 SENIORS AT ITS NEW LONGWOOD CENTER -WORKING WITH THE TOBIN COMMUNITY CENTER, PROVIDE A FREE EDUCATIONAL SESSION FOR YOUTH ON HEARING LOSS PREVENTION AT THE TOBIN COMMUNITY CENTER LOCATION. (IF IN YEARS 2 AND 3 OF THE PLAN, MEEI AND ITS COMMUNITY PARTNERS DETERMINE THAT SOMETHING DIFFERENT THAN THE ANNUAL VISION SCREENING FOR SENIORS OR HEARING EDUCATION EVENT FOR YOUTH IS NEEDED/PREFERABLE, THE PLAN WILL BE EDITED TO REFLECT SUCH CHANGES. THE OTHER COMMUNITY BENEFITS STRATEGIES ARE LIKELY TO OCCUR IN EACH OF THE THREE YEARS OF THE PLAN.) -WORKING WITH ONE OF THE EXISTING YOUTH EMPLOYMENT PARTNERS OR THE MISSION HILL YOUTH COLLABORATIVE, PROVIDE AN INTERNSHIP OPPORTUNITY TO A YOUNG PERSON IN MISSION HILL AT THE LONGWOOD FACILITY. -CONTINUE TO SUPPORT THE MISSION HILL MAIN STREET ROAD RACE (IN THE FORM OF AN ANNUAL $1000 SPONSORSHIP. -PARTICIPATE IN THE MISSION HILL HEALTH FAIR THAT IS HELD IN JUNE TO PROVIDE INFORMATION ON THE HOSPITAL AND PREVENTION AND TREATMENT OF CLINICAL ISSUES OF THE HEAD AND NECK. -ASSIST THOSE IN NEED OF FOLLOW UP CARE, INCLUDING HEARING AIDS AND GLASSES, TO OBTAIN COVERAGE FOR WHICH THEY ARE ELIGIBLE OR TO ACCESS ASSISTANCE THROUGH THE HOSPITAL (E.G., CHARITABLE CARE, FREE/REDUCE COST EYEGLASSES OR HEARING AID PROGRAMS). MEEI FILES AN ANNUAL COMMUNITY BENEFITS REPORT WITH THE MASSACHUSETTS ATTORNEY GENERAL. WHEN THE REPORTS ARE POSTED, THEY ARE AVAILABLE HERE: HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH/
SCHEDULE H, PART VI, LINE 5:	MEEI'S COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. SCREENING AND CLINICAL SERVICES 2. EDUCATION AND SUPPORT 3. ACCESS TO SERVICES/RESOURCES 4. SPONSORSHIPS CATEGORIES 1 AND 2 DRAW ON MEEI'S BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES. CATEGORY 4 REPRESENTS MEEI'S OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MEEI AND WHO ARE PROVIDING SERVICES TO MEEI'S PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERAL'S COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR FOR EACH STRATEGY IN THE CATEGORY. FISCAL YEAR 2013 WAS YEAR TWO OF MEEI'S THREE-YEAR PLAN. CATEGORY 1: SCREENING & CLINICAL SERVICES MEEI PROVIDES SCREENING AND CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF DOMESTIC VIOLENCE. SPECIFIC INITIATIVES ARE AS DESCRIBED BELOW: NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS) NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MEEI'S DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNERED WITH NHCS'S SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MEEI. WORKING WITH NHCS' SCHOOL NURSE, MARY MCNULTY-ANGLIN, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE.
CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE	SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTON'S AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MEEI'S EXPERTISE IN VISION SCREENING, MAYOR MENINO REQUESTED THAT MEEI PLAY A ROLE AT CAMP HARBOR VIEW. MEEI HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MEEI STAFF MEMBERS TRAVELED TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MEEI PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MEEI STAFF MEMBERS GIVE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. HEAD AND NECK CANCER SCREENING/LECTURE: MEEI'S DEPARTMENTS OF ENT AND SOCIAL WORK COLLABORATE TO OFFER CANCER SCREENING TO THE GENERAL PUBLIC AND TO PROVIDE SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER. SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER HAS A SUPPORT GROUP CHAPTER AT MASSACHUSETTS GENERAL HOSPITAL. MEEI COLLABORATES WITH THIS GROUP AND WITH THE HEAD AND NECK CANCER ALLIANCE TO RAISE AWARENESS DURING ORAL, HEAD AND NECK CANCER AWARENESS WEEK BY HOSTING AN EDUCATION TABLE. R.O.S.E. FUND COLLABORATION: THE R.O.S.E. FUND (REGAINING ONE'S SELF ESTEEM) IS A NON-PROFIT ORGANIZATION CHARTERED TO BREAK THE SILENCE AND THE CYCLE OF DOMESTIC VIOLENCE AND TEEN DATING VIOLENCE AND ABUSE. AMONG ITS MANY ACTIVITIES, THE R.O.S.E. FUND SCREENS AND REFERS TO MEEI SURVIVORS OF DOMESTIC VIOLENCE IN NEED OF RECONSTRUCTIVE SURGERY. MEEI'S SURGEONS PERFORM THESE LIFE-ALTERING SURGERIES FREE OF CHARGE. The Legacy Project: The Legacy Project is a grassroots effort to provide support to seniors who reside in Mission Hill. Leaders of the Legacy Project reach out to seniors living in both public housing developments and to those who are living alone, providing information about services and community events. The Legacy Project also hosts a range of educational sessions and activities in its space at the Tobin Community Center. Activities range from computer classes to exercise and dance to intergenerational forums. The Legacy Project aims to build community through inclusiveness and communication, and partners with Mass. Eye and Ear in its community benefit programming for seniors.
CATEGORY 2: EDUCATION & SUPPORT	MEEI'S CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS) AND ALSO REACH OUT TO PROVIDERS WHO INTERACT WITH SENIORS ACROSS THE COMMONWEALTH. DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW: PUBLIC FORUM ON HEARING AND HEARING LOSS: MEMBERS OF MEEI'S AUDIOLOGY DEPARTMENT PRESENTED AN 11TH ANNIVERSARY HAVE YOU HEARD? PUBLIC FORUM FEATURING EDUCATIONAL SESSIONS AND LECTURES ON HEARING AND HEARING LOSS. THIS YEAR'S SESSIONS FOCUSED ON THE MEDICAL AND SURGICAL MANAGEMENT OF HEARING LOSS, AUDIOLOGIC EVALUATION AND MANAGEMENT OF HEARING LOSS, AND SCIENTIFIC ADVANCES IN UNDERSTANDING HEARING AND HEARING LOSS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS AND INDIVIDUALS WITH HEARING LOSS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND THROUGH MEEI PARTNERSHIP WITH THE MASSACHUSETTS COUNCIL ON AGING. MEEI SURVEYS FORUM PARTICIPANTS AND WILL USE THEIR SUGGESTIONS TO DEVELOP THE EDUCATIONAL PROGRAM FOR NEXT YEAR. PUBLIC FORUM ON CONDITIONS THAT AFFECT SMELL AND TASTE: THIS YEAR, MEMBERS OF MEEI'S DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON SINUSITIS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND VIA MEEI'S PARTNERSHIP WITH THE MASSACHUSETTS COMMISSION ON AGING. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MEEI HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. THE BOSTON CURED CANCER GROUP COMES AND MEETS WITH NEW LARYNGECTOMEES, PROVIDING SUPPORT TO MEEI PATIENTS. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF IMAGE. MEEI HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MEEI PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. GLAUCOMA SUPPORT GROUP: THE GLAUCOMA FOUNDATION FUNDS GROUNDBREAKING RESEARCH AND EDUCATES THE PUBLIC ABOUT GLAUCOMA AND THE IMPORTANCE OF EARLY DETECTION TO PREVENT BLINDNESS. THE NEW ENGLAND CHAPTER OF THE GLAUCOMA FOUNDATION HOSTS A SUPPORT GROUP FOR PEOPLE WITH GLAUCOMA, THEIR CAREGIVERS, PROFESSIONALS, AND OTHERS DEDICATED TO IMPROVING THE LIVES OF THOSE WITH THIS DISEASE. MEEI PARTNERS WITH THE GLAUCOMA FOUNDATION TO PROVIDE FREE MEETING SPACE AND PUBLICITY. MEMBERS OF MEEI'S DEPARTMENT OF OPHTHALMOLOGY ARE AVAILABLE AS SPEAKERS FOR THE GROUP. MEEI HELPS PROMOTE THE GROUP BY DISTRIBUTING FLYERS IN THE HOSPITAL'S CLINICS. ATTENDEES ARE GENERALLY SENIORS FROM METRO BOSTON. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MEEI DONATES MONTHLY MEETING SPACE AND MEEI CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTON'S MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. Mission Hill Community Health Fair: Mass. Eye and Ear, Longwood, was out in full force at the Mission Hill Community Health Fair, an annual wellness event. Mass. Eye and Ear provided safety tips for hearing and vision protection and learned about disease prevention. THYROID EYE DISEASE SUPPORT GROUP: THE MASSACHUSETTS EYE AND EAR INFIRMARY OFFERS A THYROID EYE DISEASE (GRAVES' DISEASE) SUPPORT GROUP, WHICH WILL ALLOW MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES' DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MEEI DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MEEI STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION. DRESS FOR SUCCESS: THE MISSION OF DRESS FOR SUCCESS BOSTON IS TO PROMOTE THE ECONOMIC INDEPENDENCE OF DISADVANTAGED WOMEN. THEY DO THIS BY PROVIDING PROFESSIONAL ATTIRE, A NETWORK OF SUPPORT AND THE CAREER DEVELOPMENT TOOLS TO HELP WOMEN THRIVE IN WORK AND IN LIFE. MEEI MAKES AN ANNUAL DONATION TO THIS ORGANIZATION TO HELP ADVANCE ITS EFFORTS IN WORKFORCE DEVELOPMENT AMONG LOW-INCOME WOMEN. 1 TOUCH: MEEI PROVIDES FACILITIES AND SUPPORT FOR THIS ORGANIZATION'S SPECIAL SELF-DEFENSE GROUP THAT ENABLES THE BLIND AND VISUALLY IMPAIRED TO DEFEND THEMSELVES AND NAVIGATE THE WORLD WITH CONFIDENCE. Internships/Coops: Mass. Eye and Ear provides internships and coops to help get young people interested in health care so they can better care for their communities. Partners include the PIC program, John Hancock, YMCA Training, Inc, Northeastern University. The Tobin Community Center: The Tobin Community Center is one of 35 Boston Center for Youth and Families facilities which are located in every neighborhood in Boston. The Center provides recreational space and activities for youth and families, including basketball courts, workout space, a daycare facility, career learning center and a diverse range of programs and activities for all interests. The mission of BCYF is to enhance the quality of life for Boston's residents by supporting children, youth and families through a wide range of programs and services. The Center hosts Mass. Eye and Ear educational sessions. Mission Hill Youth Collaborative: The Mission Hill Youth Collaborative is a grassroots coalition of community-based organizations and institutions that promotes the well-being of the neighborhood's young people and their families through collaborative activities. MHYC brings together youth-serving organizations and institutions to address the needs of the community in light of changing economic and social conditions as well as institutional expansion. The members have advocated for more effective programming, improved resources, and built a support network for the Mission Hill youth workers, youth, and their families. John Hancock MLK Summer Scholars: The MLK Summer Scholars program addresses a critical need in the City of Boston - summer jobs for youth. Mass. Eye and Ear hires young people each summer. In additional to the experience gained on the job, interns get additional support through participation in weekly job readiness and life skills workshops. Mass. Eye and Ear provides a summer job to one MLK Scholar each summer. Boston Private Industry Council (PIC): The PIC is a public-private partnership that connects business, schools, government, labor, and community organizations to create innovative workforce solutions. PIC helps businesses develop the workforce they need and Boston residents gain access to career opportunities and higher incomes. The PIC connects youth and adults with education and employment opportunities. Mass. Eye and Ear hires 12 PIC students as summer interns. CATEGORY 3: ACCESS TO SERVICES/RESOURCES THIS CATEGORY DESCRIBES MEEI STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. THESE SERVICES AND RESOURCES ARE AS FOLLOWS:
TRANSPORTATION FOR NEEDY PATIENTS: MEEI PROVIDES FREE TAXI	TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MEEI PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MEEI PATIENTS: MEEI'S SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MEEI PATIENTS. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MEEI'S DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MEEI. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITAL'S FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MEEI'S RESEARCH LIBRARY STAFF ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MEEI HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION AND EQUIPMENT, TO PATIENTS WITH HEARING LOSS. FOR PATIENTS WHO MEET INCOME GUIDELINES, THESE SERVICES ARE PROVIDED AT NO CHARGE OR AT A REDUCED RATE. FREE PARKING: MEEI OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MEEI ALSO EXTENDS FREE PARKING TO PARTICIPANTS AT COMMUNITY BOATING, A LOCAL NONPROFIT, AND TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. CHARITABLE CARE: EACH YEAR, MEEI PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS YEAR THE HOSPITAL PROVIDED $198,116 IN FREE OR DISCOUNTED CARE TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. MEEI MAKES EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MEEI PROVIDES CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2013, MEEI'S NET CHAIRTY CARE TOTALLED $2,412,274, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MEEI'S AND THE COMMUNITY BENEFITS COMMITTEE'S COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN THE MEEI COMMUNITY BENEFITS PLAN. CATEGORY 4: SPONSORSHIPS MEEI DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT IN THE FORM OF SPONSORSHIPS TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THOSE OF MEEI AND ITS COMMUNITY BENEFITS GOALS, INCLUDING THOSE WHO ADDRESS ISSUES AFFECTED THE TARGET COMMUNITIES AND POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH.
SCHEDULE H, PART VI, LINE 7:	LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	true	RecordsMaintained

Recipient Table RecipientTable (28 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant	Address Line2AddressUS/AddressLine2
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVE	BOSTON	MA	02115	042774441	501(C)(3)	213066	RESEARCH
BOSTON UNIVERSITY
85 E NEWTON ST M-921	BOSTON	MA	02118	042103547	501(C)(3)	191201	RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS ST	BOSTON	MA	02115	042312909	501(C)(3)	464633	RESEARCH
OHIO UNIVERSITY
1 PARK PLACE	ATHENS	OH	45701	316402113	501(C)(3)	16641	RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT ST	BOSTON	MA	02114	042697983	501(C)(3)	590145	RESEARCH
MIT DIVISION OF HEALTH
77 MASS AVE	CAMBRIDGE	MA	02139	042103594	501(C)(3)	183813	RESEARCH
MAYO CLINIC
200 1ST ST SW	ROCHESTER	MN	55905	416011702	501(C)(3)	69764	RESEARCH
HARVARD UNIVERSITY
MASS HALL	CAMBRIDGE	MA	02138	042103580	501(C)(3)	801506	RESEARCH
UNIVERISITY OF SOUTHERN CALIFORNIA
3720 S FLOWER ST	LOS ANGELES	CA	90089	951642394	501(C)(3)	53207	RESEARCH
VANDERBILT MEDICAL CENTER
211 KIRKLAND HALL	NASHVILLE	TN	37240	620476822	501(C)(3)	138101	RESEARCH
WORCESTER POLYTECHNIC INSTITUTE
100 INSTITUTE RD	WORCESTER	MA	01609	042121659	501(C)(3)	282544	RESEARCH
SCHEPENS EYE RESEARCH INSTITUTE
20 STANIFORD ST	BOSTON	MA	02114	042129889	501(C)(3)	1725410	RESEARCH
UNIVERSITY OF MIAMI
1400 NW 10TH AVE	MIAMI	FL	33136	590624458	501(C)(3)	126374	RESEARCH
UNIVERSITY OF MISSISSIPPI
2500 N STATE ST	JACKSON	MS	392164505	646001159	501(C)(3)	100154	RESEARCH
BROAD INSTITUTE
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	145515	RESEARCH
MEDICAL COLLEGE OF WISCONSIN
8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	390806261	501(C)(3)	58768	RESEARCH
CARES
5000 S 5TH AVE	HINES	IL	60141	363334177	501(C)(3)	170852	RESEARCH
DREXEL UNIVERSITY
3201 ARCH ST 100	PHILADELPHIA	PA	19104	231352630	501(C)(3)	85105	RESEARCH
LAWRENCE LIVERMORE NATIONAL SECURITY LLC
MS L 397 7000 E AVE	LIVERMORE	CA	94550	205624386	OTHER	10798	RESEARCH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
243 CHARLES STREET	BOSTON	MA	02114	222658209	501(C)(3)	9966948	INSTITUTIONAL
RHODE ISLAND HOSPITAL
593 Eddy Street	Providence	RI	029034923	050258954	501(c)(3)	237616	RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SD
9500 Gilman Dr MC0934	San Diego	CA	92023	956006144	501(c)(3)	36828	RESEARCH
JOAN&SANFORD IWEILL MEDICAL COLL OF CORNEL UNIV
1305 New York Ave	New York	NY	10065	150532082	501(c)(3)	100016	RESEARCH
MARSHFIELD CLINICAL RESEARCH FOUNDATION
1000 North Oak Avenue	Marshfield	WI	54449	390452970	501(c)(3)	48625	RESEARCH
CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE
10900 Euclid Ave	Cleveland	OH	441067015	341018992	501(c)(3)	72220	RESEARCH
BOSTON MEDICAL CENTER
660 Harrison Ave	Boston	MA	021182393	043314093	501(c)(3)	36102	RESEARCH	2nd Floor
UNIVERSITY OF WASHINGTON
1730 Minor Ave STE 1360	Seattle	WA	98101	916001537	501(c)(3)	29806	RESEARCH
SCHEPENS EYE RESEARCH INSTITUTE
20 STANIFORD ST	BOSTON	MA	02114	042129889	501(C)(3)	570606	INSTITUTIONAL

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	27	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	1	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	SCHEDULE I, PART I, LINE 2:	Identifier
Explanation	SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	true	SeverancePayment
Supplemental Nonqual Retire Plan	true	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	false	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	false	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	false	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	false	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	false	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	true	AnyNonFixedPayments
Initial Contract Exception	false	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (22 entries)

TitleTitle	Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
JOHN R FERNANDEZ
PRESIDENT	640224	0	169660	0	810	0	132843	0	22198	0	965735	0	0	0
JOAN W MILLER MD
DIRECTOR	0	677686	0	85486	0	17833	0	34495	0	21811	0	837311	0	0
JOSEPH B NADOL JR MD
DIRECTOR	0	685358	0	70882	0	25933	0	34495	0	28259	0	844927	0	0
SUSAN WILLIAMS
ASST SEC/GENERAL COUNSEL	225529	0	25509	0	17574	0	10660	0	8404	0	287676	0	0	0
MAUREEN KELLEY
ASST SECRETARY	168771	0	3250	0	362	0	6857	0	21405	0	200645	0	0	0
CAROLANN WILLIAMS
CFO & VP FINANCE AND ADMIN	286775	0	73660	0	408	0	9982	0	1520	0	372345	0	0	0
BARBARA J SCULLY
DIRECTOR PROF REV CYCLE	164713	0	5000	0	216	0	13123	0	21336	0	204388	0	0	0
EILEEN O LOWELL
CNO & VP PAT CARE SVS	213674	0	26744	0	894	0	12300	0	21611	0	275223	0	0	0
ALAN K LONG
VP RESEARCH ADMINISTRATION	184720	0	18768	0	18220	0	7541	0	1006	0	230255	0	0	0
CHRISTINE REGAN
VP HUMAN RESOURCES	212782	0	22758	0	2209	0	14039	0	21336	0	273124	0	0	0
KENNETH HOLMES
CFO MEEA	222140	0	55150	0	17813	0	6857	0	21762	0	323722	0	0	0
JEAN E MACQUIDDY
VP OTOLARYNGOLOGY	231436	0	16059	0	2754	0	24781	0	9061	0	284091	0	0	0
JEFFREY J PIKE
CHIEF OPERATING OFFICER	273668	0	72376	0	427	0	10372	0	8571	0	365414	0	0	0
JAVIER BALLOFFET
VP OPHTHALMOLOGY	225600	0	68339	0	19415	0	14617	0	21788	0	349759	0	0	0
JENNIFER STREET
VP COMMUNICATIONS & PLANNING	266009	0	72514	0	643	0	11010	0	21990	0	372166	0	0	0
MELISSA M PAUL
CHIEF DEVELOPMENT OFFICER	200784	0	22548	0	6163	0	14440	0	21695	0	265630	0	0	0
GLENN W BUNTING
VOICE & SPEECH CLINICAL DIR	175948	0	1500	0	667	0	14482	0	23728	0	216325	0	0	0
GREGORY J DONNELLY
ADMIN DIR ANCILLARY SVS	167657	0	8755	0	148	0	9468	0	21129	0	207157	0	0	0
PETER J CHINETTI
FORMER VP FINANCE	0	0	0	0	110893	0	0	0	225	0	111118	0	0	0
PHILLIP C JOHNSON
DIR FINANCIAL OPERATIONS	161964	0	10000	0	17658	0	18137	0	21382	0	229141	0	0	0
RALPH T PELOSI
DIRECTOR FACILITIES PLANNING	163958	0	8498	0	1472	0	6268	0	208	0	180404	0	0	0
ALEC CHELOFF
CHIEF INFORMATION OFFICER	132958	0	0	0	54245	0	3460	0	16168	0	206831	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII

Field	Value	IRS element (for citing)
Identifier	SCHEDULE J, PART I, LINE 4A:	Identifier
Explanation	In connection with his departure effective May 1, 2011, Peter Chinetti received 12 months of Salary and Benefit continuation. In connection with his departure effective June 30, 2012, Alec Cheloff received 4 months of Salary and Benefit continuation. SCHEDULE J, PART I, LINE 4B: John Fernandez participates in a Deferred Compensation arrangement with Massachusetts Eye and Ear. Under this agreement, Mr. Fernandez will be credited $120,000 for CALENDAR YEAR 2012. Each annual credit will vest on the fourth anniversary of the date such credit was made or upon (1) the attainment of the age of 65 while employed; (2) termination without cause or resignation for good reason; (3) death; (4) disability; or (5) change of control of MASSACHUSETTS Eye and Ear within the meaning of section 409A of the Internal Revenue Code. SCHEDULE J, PART I, LINE 7: The Board of Trustees of the Massachusetts Eye and Ear Infirmary, upon recommendations of the Compensation Committee, approve a bonus program for certain individuals listed on the Schedule J. The program requires that supervisory personnel make the determination of (1) eligibility and (2) amount of bonus dollars based on overall job performance. The CEO of the Infirmary has the authority to (1) overrule recommendations made by supervisors and (2) make bonus determinations for Vice President level personnel. The Compensation Committee of the board has the final authority for bonuses paid to the CEO as well as the Vice Presidents. Total Compensation for listed individuals, including bonus payments, was analyzed by independent compensation consultants, determined to be reasonable compensation, and approved by the Board. No compensation payment can be made in excess of these amounts.	Explanation

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (3 entries)

Bond ReferenceBondReferenceCd	Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
A	042456011	57586EWL1	2010-09-29	63156092	FACILITY IMPROVEMENTS	false	false	false
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
B	042456011	57586ELD1	2007-03-22	20000000	FACILITY IMPROVEMENTS	false	false	true
MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES
C	042456011	57586ELD1	2005-02-25	13695000	FACILITY IMPROVEMENTS	false	false	true

Form990 Schedule K Part II Form990ScheduleKPartII (3 entries)

Bond ReferenceBondReferenceCd	Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Capitalized InterestCapitalizedInterest	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Capital ExpendituresCapitalExpenditures	Amount UnspentAmountUnspent	Current RefundingCurrentRefunding	Advance RefundingAdvanceRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind	Year Of Subst CompletionYearOfSubstCompletion
A	0	63156092	4993936	5191181	1360310	42858859	8751806	false	false	false	true
B	7815000	20000000	121854	0	108810	19769336	0	false	false	true	true	2010
C	5902139	13695000	77930	0	71758	13545312	0	false	false	true	true	2009

Form990 Schedule K Part III Form990ScheduleKPartIII (3 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Bond Iss Meet Prvt Security Pay TestBondIssMeetPrvtSecurityPayTest	Non Qualified Bond Remed ProcdrsNonQualifiedBondRemedProcdrs
A	false	false	false	false	false	true
B	false	false	false	false	false	true
C	false	false	false	false	false	true

Form990 Schedule K Part IV Form990ScheduleKPartIV (3 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiled	Rebate Not Due YetRebateNotDueYet	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Business Name Line1NameOfGICProvider/BusinessNameLine1	Gross Proceeds InvestedGrossProceedsInvested	Written Proc To Monitor ReqsWrittenProcToMonitorReqs
0
A	false	true	false	false	false	0	false	false
0
B	true		true	false	false	0	false
0
C	true		true	false	false	0	false	false

Form990 Schedule K Part V Form990ScheduleKPartV (3 entries)

Bond ReferenceBondReferenceCd	Proc To Undertk Corrective ActionProcToUndertkCorrectiveAction
A	true
B	true
C	true

Form990 Schedule K Part VI Form990ScheduleKPartVI (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
PART I, BOND (A), COLUMN (F):	0	THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS.
PART I, BOND (B), COLUMN (F):	0	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.
PART I, BOND (C), COLUMN (F):	0	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.

Schedule L IRS990ScheduleL

Loan Table LoanTable

Field	Value	IRS element (for citing)
Name Person	KENNETH HOLMES	NamePerson
Purpose Of Loan	HOUSING	PurposeOfLoan
Loan From Organization	X	LoanFromOrganization
Original Principal	$50,000	OriginalPrincipalAmount
Balance Due	10000	BalanceDue
Default	false	Default
Approved By Board	false	ApprovedByBoard
Written Agreement	true	WrittenAgreement

Field	Value	IRS element (for citing)
Total Balance Due	10000	TotalBalanceDue

Form990 Schedule L Part IV Form990ScheduleLPartIV

Name Of Interested Person NameOfInterestedPerson

Field	Value	IRS element (for citing)
Name Person	JOAN MILLER MD	NamePerson

Field	Value	IRS element (for citing)
Relationship	DRCTR IS LICENSOR TO ORG	Relationship
Amount Of Transaction	244124	AmountOfTransaction
Description Of Transaction	PATENT LICENSE PROCEEDS	DescriptionOfTransaction
Sharing Of Revenues	false	SharingOfRevenues

Form990 Schedule L Part V Form990ScheduleLPartV

Field	Value	IRS element (for citing)
Identifier	SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS	Identifier
Explanation	(A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY.	Explanation

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (16 entries)

IdentifierIdentifier	ExplanationExplanation	Return ReferenceReturnReference
FORM 990, PART I, LINE 1 & PART III, LINE 1:	THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI").
FORM 990, PART III, LINE 4A:	Ophthalmology: - A New, Complete Catalogue: Gene Expression in the Human Retina Published. Michael Farkas, PhD, Eric Pierce, MD, PhD, and investigators in the HMS Ophthalmology Ocular Genomics Institute (OGI) at Mass. Eye and Ear recently published the most thorough description of gene expression in the human retina (BMC Genomics, July 2013). According to researchers, documenting the entirety of these genetic data into a catalogue is crucial for understanding how diseases of the eye develop and lead to vision loss. Investigators used a technique called RNA sequencing (RNA-seq) to identify all of the messenger RNAs (mRNAs) produced in the human retina. This catalog of expressed genes, or transcriptome, revealed that the majority of the 20,000+ genes in the human body are expressed in the retina. The researchers also identified almost 30,000 novel exons (portions of the genome that are used to encode proteins or other genetic elements) and over 100 potential novel genes that had not been identified previously. To date, investigators have identified more than 200 retinal degeneration disease genes, but identification of new exons used in the retina may help find the cause of disease in currently undiagnosed patients. - First Corneal Transplant Performed With Pre-loaded Tissue. Roberto Pineda, II, MD performed a series of groundbreaking procedures in April 2013 when he utilized EndoGlide (Angiotech Pharmaceuticals, Inc.) cartridges pre-loaded at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL for endothelial keratoplasty transplant procedures at the Mass. Eye and Ear. Dr. Pineda utilized donor endothelial tissue that was pre-cut, trephined and pre-loaded into the devices before being sent to the Mass. Eye and Ear for transplantation. In 2012, the LEITR presented a pre-clinical study at the 2012 ARVO Annual Meeting reporting that eye banks are able to safely prepare and load corneal tissue into the EndoGlide cartridges. - Mass. Eye and Ear Joins Global Alliance to Share Genomic and Clinical Data. Massachusetts Eye and Ear is among the nearly 70 leading health care, research, and disease advocacy organizations that have joined together to form an international alliance dedicated to enabling secure sharing of genomic and clinical data. The alliance will support the formation of large, shared datasets that will allow researchers around the globe to identify target pathways and develop transformational therapies for patients. The group will develop methods and policies to share information responsibly, while protecting patient privacy and the public interest. Research Successes: - 238 Proposals - 88 Awards - Total grants awarded: $32,740,597 Retina: - Members of the Angiogenesis Laboratory investigated the mechanism of cell death in retinal degenerations and showed that RIP Kinase mediated programmed necrosis, not apoptosis, is a key mediator of photoreceptor cell loss and damage associated molecular pattern mediated inflammation in animal models of inherited retinal degenerations (IRD) and dry AMD. This can lead to novel therapeutics for dry AMD, IRD, and other retinal disorders. - Researchers from the Angiogenesis Laboratory examined the role of the energy sensor for the cell called AMPK and showed it to regulate vascular cell permeability and angiogenesis. This can lead to a new class of anti-leakage and anti-angiogenesis drugs. - Studied non-chemotherapy drugs for retinoblastoma and showed the role of a small activator of the metabolic and energy sensor AMPK in inhibiting retinoblastoma cell growth in vivo in an animal model. This could lead to gentler therapies for children with retinoblastoma. - Conducted clinicopathologic and immunohistochemical studies of conjunctival large cell acanthoma, epidermoid dysplasia, and squamous papilloma. Showed that conjunctival large cell acanthoma is a morphologically distinctive clonal entity with clinical and immunohistochemical phenotypic characteristics denoting a dysplasia of minimal severity. Because of recurrences without invasion, it requires treatment. - Presented an improved technique of experimental retinal detachment in rodents that result in more reproducible results. - Showed that a simple non-invasive test can be used to monitor a rare inflammatory disease of the retina called ampiginous choroiditis. - Presented a comprehensive review on photoreceptor cell death pathways and neuroprotection strategies in Progress in Retina Eye Research. - Was a participating center in the Age-Related Eye Disease Study 2 (AREDS2), a large multicenter clinical trial funded by the National Eye Institute, which clarified the effectiveness of specific dietary supplement formulations for the treatment of AMD. - Provided pre-clinical evidence that ranibizumab, a vascular endothelial growth factor inhibitor, may prevent vitreoretinopathy (PVR), a serious complication that can occur after surgical repair of retinal detachment. - Demonstrated that converting patients with chronic neovascular AMD to aflibercept (Eylea) results in stabilized vision and improved anatomic outcomes, while allowing injection intervals to be extended. - Showed that CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. - Demonstrated that AMD-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.	RESEARCH
Ocular Genomics Institute (OGI):	- Inherited macular degeneration: In a study published in the journal Human Molecular Genetics, members of the OGI reported for the first time that that the complement system plays a critical role in the early stage of an inherited macular degeneration, in addition to being associated with age-related macular degeneration. This is important because it provides insight into how alterations in complement system components contribute to macular disease. - Human retinal transcriptome: Researchers from the group reported the most thorough description of gene expression in the human retina reported to date. In the study published in the journal BMC Genomics, Drs. Michael Farkas, Eric Pierce and colleagues in the Ocular Genomics Institute at Mass. Eye and Ear reported a complete catalog of the genes expressed in the retina. This is a valuable resource for the vision research community, and the data are available via the OGI website (see http://oculargenomics.meei.harvard.edu/index.php/ret-trans). - Reported that the adeno-associated virus AAV9 selectively targets cone photoreceptors in the non-human primate. - Milestones from the OGI include: Genomics core facility open, and providing research genomics services as well as CLIA-certified genetic diagonstic testing (information available via OGI website; see http://oculargenomics.meei.harvard.edu/index.php/gc and http://oculargenomics.meei.harvard.edu/index.php/gdt, respectively). - Recruited Dr. Xiaowu Gai to lead the Bioinformatics program of the OGI, and establish a Bioinformatics Shared Resource for the Department. Dr. Gai is a talented informaticist, and is currently Director of Biomedical Informatics, Loyola University Chicago Stritch School of Medicine. - The first OGI course "Genetics and genomics of ocular disease," directed by Dr. Janey Wiggs was presented as a satellite meeting of the American Society of Human Genetics. - Berman Gund Laboratory for the Study of Retinal Degenerations - Used whole-genome sequencing to identify pathogenic DNA structural changes and a new disease gene for retinitis pigmentosa. Cornea: - Completed a clinical study evaluating the efficacy of a topical combined anti-PDGF and anti-VEGF therapy in corneal angiogenesis. - Created and validated an ocular redness continuous (0.0 - 100.0) scale using a novel, state-of-the-art computer program. - Completed a study assessing the use of tear osmolarity as a new method to diagnose and monitor dry eye disease. - Developed telomerase-immortalized corneal endothelial cell line which will provide a new tool for the in vitro study of corneal endothelial cell biology and will be made available to the NIH community. - Determined that deficiency in Nrf2-regulated pathway is involved in the pathogenesis of Fuchs endothelial corneal dystrophy. - Determined that corneal limbal fibroblasts can be differentiated into corneal epithelial cells thus serving as a novel source of corneal epithelium usually destroyed in limbal stem cell deficiency disorders. - Demonstrated the presence of the integrin MadCAM-1 in the ocular surface vasculature and determined its role in the recruitment of corneal immune cells. - First human implantation of an intraocular device to measure IOP by telemetry. This may resolve the inability to measure IOP in keratoprosthesis patients. - Conducted the first large scale cataract surgery outcomes review (18,000 cases) in the UK independent sector (private-sector owned treatment centers contracted within the English National Health Service to treat NHS patients free at the point of use). - Demonstrated with live corneal imaging that unilateral corneal infections, including in herpes zoster ophthalmicus, lead to contralateral changes in corneal nerves in the unaffected eye, suggesting neuro-regulatory mechanisms between eyes. - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month. - Determined that devices used in PROSE treatment can be customized to accommodate any eye with keratoconus or post-LASIK ectasia regardless of disease severity. - Performed first collagen cross-linking in Boston, an experimental treatment for keratoconus, under the auspices of an FDA-sanctioned clinical trial. - Completed a study on worldwide incidence of infections after keratoprosthesis, and evaluation of optimal antibiotics prophylaxis. - Determined risk of light damage to retina during keratoprosthesis surgery. - Received FDA approval for the use of titanium in keratoprosthesis. - Quantified the risk of glaucoma after keratoprosthesis. - Constructed a new glaucoma valve. - Demonstrated radical reduction of complications by using oversized back plates in keratoprosthesis. - Published the largest ever series of pediatric herpes simplex. Demonstrated use of acyclovir in children and recommended treatment and maintenance doses (Liu et al, Ophthalmology 2012). - Demonstrated oversized backplates for KPro associated with better wound anatomy to try to reduce RPM formation (Cruzat et al, Cornea 2013) - MEEI will be a premier site for the upcoming Zoster Eye Disease Study (ZEDS), which will evaluate the effect of long-term systemic antiviral of the ophthalmic complications of shingles. Drs Colby and Langston will serve on the Executive Committee for this study. - Completed and have in press in Cornea clinical study showing that ganciclovir gel (Zirgan) is rapidly effective in healing Herpes zoster pseudodendritic ulcers of the cornea. - Completed clinical study "Patients with Infectious Keratitis Demonstrate Persistent and Long-term Increase in Immune cells and Diminished Subbasal Corneal Nerves After Cessation of Anti-Microbial Therapy -- A Laser in vivo Confocal Microscopy Study." - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month, published in Biomaterials. - Reported the findings from a large, multi-center study that found that excellent retention of the Type I Boston Kpro - 93% of the 300 Kpro implants were retained at their last follow-up, corresponding to a retention time of 396 patient-years or 1.42 years/keratoprosthesis in Ophthalmology. - Validated measurement of corneal dendritiform cells by in vivo confocal microscopy as a measure to assess ocular surface inflammation - Completed large multi-center clinical trial, demonstrating that combination of contact lenses and contact lens solutions are more important that each factor alone in inducing ocular surface inflammation - Launched grant from the Department of Defense to conduct a multi-center clinical trial to assess the safety and efficacy of an anti-VEGF in patients who are at high-risk for graft rejection following their corneal transplant. - Completed several clinical studies demonstrating that the use of autologous serum tears result in corneal nerve regeneration and in reversal of symptoms of corneal neuralgia and light sensitivity in patients with corneal neuropathies. - Completed a study evaluating the efficacy of a steroid vs. a steroid and antibiotic in patients with ocular inflammation related to dry eye disease - Reported on patients with bilateral corneal ulceration in ocular graft-versus-host disease. - Created novel software programs to quantify ocular surface staining and ocular redness, methodologies which will allow for more accurate measurements of ocular disease and progression. - Generated a large database on patients with ocular graft-versus-host disease. - Developed a surgical safety checklist for refractive procedures in association with the Institute for Safety in Office-based Surgery (ISOBS). - Published a novel method for cross linking ectatic corneas.
Glaucoma:	- Contributed to an international effort reporting on 27 genetic loci that explain variance in central corneal thickness. Six of these loci are also associated with keratoconus and 1 represented a new locus for primary open-angle glaucoma. This work was published in Nature Genetics. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, glaucoma investigators used a case-only approach to demonstrate that genetic loci in the CDKN2B-AS1 region alter optic nerve vulnerability to glaucomatous damage. - Demonstrated an inverse relation between serum TNF receptor 2 levels and incident normal tension glaucoma among women. This study is based on a case control group nested within a population-based study (the Nurses Health Study) and serum samples on cases were collected prior to when glaucoma treatment was instituted. To the best of our knowledge, this is the first demonstration of a serum biomarker that is associated with a reduced risk of open-angle glaucoma. - Described the results of a randomized trial comparing the impact of fixed combination timolol-dorzolamide to fixed combination timolol-brimonidine in the co-regulation of retinal blood flow and ocular perfusion pressure. - Dr. Emmanuel Buys (MGH) and several members of the Harvard Glaucoma Center of Excellence, described a murine model of open angle glaucoma that is based on knocking out the intracellular receptor for nitric oxide, soluble guanylate cyclase. These mice develop modest, age-related increases in IOP and optic nerve degeneration that mimics the normal tension variant of primary open-angle glaucoma. More significantly, Dr. Buys and co-workers demonstrated that a common variant in the gene region for soluble guanylate cyclase is associated with primary open angle glaucoma that presents with paracentral visual loss. - Led an effort to demonstrate that several of the prostaglandin analogues in current use to treat glaucoma are strongly associated with atrophy of the periorbital fat, upper eyelid ptosis and loss of low eyelid steatoblepharon. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, investigators evaluated the collective relation between common genetic polymorphisms involved in estrogen metabolism and primary open-angle glaucoma. The work demonstrates that this panel of estrogen metabolizing polymorphisms is associated with primary open glaucoma in women but not in men. - Confirmed that TMCO1 loci are associated with intraocular pressure in conjunction with the GLAUGEN (Glaucoma Genes and Environment) study, the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, and the Age-related Macular Degeneration- Michigan, Mayo, AREDS and Pennsylvania study investigators. - Contributed to the International Consortium of African Ancestry Research in Glaucoma and demonstrated that genetic loci in the CDKN2B-AS1 region are associated with primary-open angle glaucoma among African Americans but not among African people derived from Ghana.
OTOLARYNGOLOGY:	- Benjamin Bleier, M.D., Nicolas Busaba, M.D., Stacey Gray, M.D., and Eric Holbrook, M.D., have co-authored a study on the effectiveness of different treatments of nosebleeds for adults. The study, published in Otolaryngology-Head and Neck Surgery, found that in a limited observation, surgical and/or medical intervention offered the best outcome in adults with nosebleeds. - Albert Edge, Ph.D., is the lead author of a study conducted with hearing researchers at Massachusetts Eye and Ear Infirmary and Harvard Medical School who have, for the first time, regenerated sensory hair cells in the ear, resulting in restored hearing to noise-damaged ears. The Jan. 10, 2013 issue of Neuron features the research study, as well as a video discussion with Dr. Edge. - In a May 2013 issue of Cancer, investigators at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary, including Edmund Mroz, Ph.D., Aaron Tward, M.D., Ph.D., and James Rocco, M.D., Ph.D., describe how their measure of heterogeneity of cells within a tumor appears to predict treatment outcomes of patients and was a better predictor of survival than most traditional risk factors in a small group of patients with squamous cell carcinoma, the most common type of head and neck cancer. - In a March issue of the Journal of Neuroscience, researchers found that noise exposure is clearly more dangerous than typically thought and gained insight into why it is difficult for some people to hear in "everyday" noisy environments. Stephane Maison, Ph.D. and M. Charles Liberman, Ph.D., were lead authors on this publication. - Led by Daniel Lee, M.D., researchers from the Wilson Auditory Brainstem Implant Program at Massachusetts Eye and Ear are currently conducting the only FDA-approved clinical trial in the U.S. for adult deaf patients who do not have NF2 to receive the ABI. The study was given clearance by the Human Studies Committees of Mass. Eye and Ear and Harvard Medical School in November 2012. A second study for pediatric patients who are deaf but do no have NF2 to receive the ABI was FDA-approved in May 2013. Radiology: - Renee Mitchell, Lead CT/XRAY radiologic technologist, performed high resolution cadaveric sinus scans for Dr. Benjamin Bleier for image guidance during the resident sinus dissection courses. - Renee Mitchell worked with Dr. Yoojin Chung and Jennifer O'Malley on a study with Dr. Bertrand Delgutte who is the principal investigator of these studies, where cochlear implanted rabbits are part of projects investigating neural responses to electrical stimulation and brain plasticity in animal models of human cochlear implants at the Eaton-Peabody Lab. The imaging scans are to ascertain the proper positioning of the CI's in these animals.
FORM 990, PART III, LINE 4B:	ACADEMIC PROGRAMS: OTOLARYNGOLOGY: - 18 RESIDENTS - 11 CLINICAL FELLOWS - 49 RESEARCH FELLOWS - 2 RESEARCH RESIDENTS OPHTHALMOLOGY: - 23 RESIDENTS - 26 CLINICAL FELLOWS - 102 RESEARCH FELLOWS Ophthalmology: - International Collaborations. The Department continues to build upon existing relationships that HMS Ophthalmology faculty and Chinese colleagues have been cultivating for several years. Faculty from Mass. Eye and Ear and Schepens traveled to China in a series of visits this year to exchange perspectives on research efforts and clinical care and management practices. One key mission of the trip was to strategically and cooperatively identify training opportunities as part of the Department's new International Research & Training program, which is now working smoothly to place trainees in department laboratories. Faculty from Eye and ENT Hospital of Fudan University visited in June for the Annual & Alumni Department meeting and a series of discussions. - Dong Feng Chen, MD, PhD Chair of Women's Eye Health.org is collaborating with associates from Peking University First Hospital to produce an educational TV series about eye disease for Beijing TV. The series complements the organization's worldwide outreach efforts to build awareness of the prevalence of eye disease in women. - The new Office of Global Surgery and Health established at Mass. Eye and Ear partners with training hospitals in underserved countries to improve residency programs in ophthalmology through onsite surgical instruction, remote education innovation and opportunities for research collaboration. - Inaugural HMS Ophthalmology Faculty Retreat. More than 100 Harvard Medical School (HMS) Department of Ophthalmology faculty members joined together for a two-day retreat at Wentworth by the Sea in Newcastle, NH on April 5-6, 2013. The inaugural event united clinicians and scientists from across the department and presented a forum for candid discussion, dialogue and exchange that aimed to coalesce translational efforts and more rapidly advance bench to bedside discovery. The retreat also provided a relaxed and casual "meet-and-greet" venue for faculty. Topics of discussion included overviews of the Department's growing Centers of Excellence and Institutes, expanded international collaborations, strengthened department-industry partnerships, and faculty development efforts. - Faculty Promotions and Appointments: HMS Appointments: - Endowed Professorships: - Patricia D'Amore, PhD, MBA, FARVO, The Charles L. Schepens Professor of Ophthalmology - Dean Eliott, MD, Stelios Evangelos Gragoudas Associate Professor of Ophthalmology - Professor of Ophthalmology: - Darlene Dartt, PhD, FARVO, Schepens/Mass. Eye and Ear - Associate Professor of Ophthalmology: - Don Bienfang, MD, Brigham and Women's Hospital - Assistant Professor of Ophthalmology: - Joseph Ciolino, MD, Mass. Eye and Ear - Suzanne Freitag, MD, Mass. Eye and Ear - Qin Liu, MD, PhD, Mass. Eye and Ear - Vincent Patalano, MD, Cambridge Health Alliance - Luk Vandenberghe, PhD, MSc, Mass. Eye and Ear - Michael Yoon, MD, Mass. Eye and Ear - Instructor in Ophthalmology: - Andrea Cruzat, MD, Schepens/Mass. Eye and Ear - Juan Ding, PhD, Schepens/Mass. Eye and Ear - Tobias Elze, PhD, Schepens/Mass. Eye and Ear - Ahmad Kheirkhah, MD, Schepens/Mass. Eye and Ear - Haijiang Lin, MD, PhD, Mass. Eye and Ear - Eleftherios Paschalis, PhD, MSc, Mass. Eye and Ear - Daniel Sun, PhD, OD, Mass. Eye and Ear - Xiaohong Zhou, MD, PhD, Mass. Eye and Ear - Cornea Center of Excellence hosts three days of unparalleled learning and discussion. The HMS Department of Ophthalmology Cornea Center of Excellence (COE) took center stage on October 17-19th when it hosted its first International Workshop at Mass. Eye and Ear followed by the 28th Biennial Cornea Conference held at the Schepens Starr Center for Scientific Communications. The inaugural International Workshop brought together a multidisciplinary group of more than 20 scholars. Both physicians and scientific researchers presented current research findings, exchanged scientific ideas, and strengthened international collaboration in the field of cornea and ocular surface research. The scientific program focused on virology, immune regulation, ocular surface, new imaging technologies, and regenerative medicine. Notably, Schepens alumnus and Professor and Chair of Ophthalmology at Kyoto Prefectural University of Medicine, Shigeru Kinoshita, MD, PhD, attended the workshop and also presented "Future Therapeutic Modalities for Devastating Ocular Surface and Corneal Disorders" during Grand Rounds earlier in the day. - The 4th Annual Mass. Eye and Ear Vitrectomy Course. The Course received unanimously positive feedback from this year's 48 fellows and six residents who attended from around the country. The free, two-day training intensive, held on July 19-20, 2013 attracted 33 world-class faculty members who joined together to deliver a brief, but comprehensive, introduction to the theory and practice of vitreoretinal surgery. Organized by Dean Eliott, MD, John Loewenstein, MD, and Demetrios Vavvas, MD, PhD, the course consisted of lectures, panel discussions, surgical simulation lab, and surgical wet lab in a setting with low student-to-teacher ratio. Emphasis on hands-on training and close interaction with faculty has made this course a tremendous success since its inauguration. All of the faculty have volunteered to return next year. since its inauguration. All of the faculty have volunteered to return next year.	EDUCATION
OTOLARYNGOLOGY:	- Professor: - Christopher Shera, Ph.D. - Associate Professor: - Daniel Lee, M.D. - Assistant Professor: - Benjamin Bleier, M.D. - Robin Lindsay, M.D. - Stephane Maison, Ph.D. - Instructor (promoted from training status): - Mitchell Day, Ph.D. - Mingqian Huang, Ph.D. - Albena Kantardzhieva, Ph.D. - This year the department celebrated the class of 2013 at a June 21st ceremony held in the Meltzer auditorium. Our outstanding graduates included Drs. Sang Kim, Josh Meier, Daniel Roberts, and Josef Shargorodsky. We also welcomed five new residents to the program this year, Drs. Pete Creighton, Taha Jan, Brian Lin, Matthew Naunheim, and George Scangas. - The Department hosted the 12th International Facial Nerve Symposium over the weekend of June 28th, directed by Drs. Tessa Hadlock, Mack Cheney, and Michael McKenna. This four-day, lecture filled symposium included daily keynote addresses on topics ranging from facial nerve reconstruction to social functioning with facial paralysis. - A number of Mass. Eye and Ear physicians attended the International Federation of Otolaryngology Societies (IFOS) meetings in Seoul, Korea in May 2013, including Drs. Michael Rho, Eric Holbrook, Stacey Gray, Derrick Lin, James Rocco, Daniel Lee, Gregory Randolph, Nicolas Busaba, Phillip Song, Ramon Franco, and Head and Neck Surgical Oncology fellow Dr. Alice Lin. The group presented multiple lectures, panels, and courses to an international audience of otolaryngologists, with more than 4,500 attendees. The group plans to create an MEEI program for the next IFOS meeting in Paris in 2017. - Stacey Gray, M.D., was involved in a number of conferences in her field this year, serving as invited speaker and panel moderator for many of these engagements. This year she contributed to the Harvard Macy Institute Program for Educators in the Health Professions, the Combined Otolaryngology Spring Meeting in Orlando, the American Rhinology Society Summer Symposium in Chicago, the International Federation of Oto-Rhino-Laryngological Societies World Congress in Seoul, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. - Christopher Halpin, Ph.D., delivered the keynote address at the Spanish Congress of Audiology, Royal College of Physicians, Seville, titled "Clinical word recognition and audiologic disorders." Dr. Halpin also spoke at the Sociedad Espanola de Otorrhinolaryngology in Madrid, Spain in 2013. - Eric Holbrook, M.D., has been invited to speak and serve as a faculty member for the European Rhinology Society/ISIAN Congress in Amsterdam in 2014. - Richard Lewis, M.D., was an invited speaker on "Central vestibular processing investigated with electrical stimulation of canal ampullary nerves," at the Sensing Motion for Action Symposium in Montreal in July 2013. Dr. Lewis also spoke on "Investigating vestibular function with perceptual threshold testing," at Spaulding Hospital in Boston in April 2013. - Daniel Polley, Ph.D., lectured at the February 2013 meeting for the Association of Research in Otolaryngology on cortical modulation of sound representations in the auditory thalamus. - Gregory Randolph, M.D., served as panel moderator of "Avoidance of Complication in Thyroid/Parathyroid Surgery," and as panelist for "Papillary Carcinoma: prophylactic central neck dissection" at the American Cancer Society meetings. Dr. Randolph also served on the steering committee for the 2nd World Congress on Thyroid Cancer, held in Toronto from July 10th through the 14th in 2013. The Congress is a global multidisciplinary meeting of all specialists involved in the treatment of thyroid nodule disease and thyroid cancer. - Konstantina Stankovic, M.D., Ph.D., presented at the February 2013 Association for Research in Otolaryngology (ARO) meeting on a selection of her unpublished work, including, "Loss of FGF23 signaling results in mixed hearing loss and middle ear malformation," "Molecular network analysis of hearing loss and hypogonadism," "Examining the role of Gtf2ird1 deletion in auditory physiology and behavior in a murine model of Williams-Beuren Syndrome," and "Finding characteristic DFNA9 cochlin-staining eosinophilic deposits in the middle ear." Dr. Stankovic also presented at the American Otologic Society and American Neurotology Society meetings in April 2013 on the following topics, "Metabolomics analysis of pharmacotherapies for sensorineural hearing loss," "Aspirin intake correlates with halted growth of sporatic vestibular schwannoma in vivo," and "Molecular network analysis of sporadic vestibular schwannoma pathobiology highlights actin as a major modulator of tumor growth." Radiology: - The radiologists wrote or participated in 34 papers including:Borodic GE, Caruso PA, Acquadro M, Chick S. "Parry-Romberg Syndrome Vasculopathy and its Treatment with Botulinum Toxin". Ophthal Plast Reconstr Surg May 2013. - Gao Y, Moonis G, Cunnane ME, Eisenberg RL. "Lacrimal Gland Masses". Am J Roentgenol 2013 Sep; 201(3):W371-81. - Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A, Kamani D, Randolph GW. "Papillary Thyroid Carcinoma Nodal Surgery Directed by a Preoperative Radiographic Map Utilizing CT Scan and Ultrasound in all Primary and Reoperative Patients". Head Neck 2013 Apr; 2:232-77. - Quesnel AM, Moonis G, Appel J, O'Malley JT, McKenna MJ, Curtin HD, Merchant SN. "Correlation of Computed Tomography with Histopathology in Otosclerosis". Otol Neurotol 2013 Jan; 34(1):22-8. - Juliano AF, Ginat D, Moonis G. "Imaging Review of the Temporal Bone-Part I: Anatomy and Inflammatory and Neoplastic Processes". Radiol 2013 Oct; 269(1):17-33. - Ginat D, Freitag SK, Kieff D, Grove A, Fay A, Cunnane ME, Moonis G. "Radiographic Patterns of Orbital Involvement in IgG4-Related Disease". Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6. Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6.
FORM 990, PART III, LINE 4C:	Ophthalmology: - Mass. Eye and Ear, Longwood. Patient visits to the new Mass. Eye and Ear, Longwood multi-specialty ambulatory care center at 800 Huntington Avenue have climbed steadily since the facility opened its doors to patients in December, 2012. During 10 months in FY13, the Longwood medical team and staff handled nearly nine thousand patient visits. Four additional clinicians joined the practice this fall to keep pace with growth, bringing the number of Longwood practitioners to 13. Clinicians handle a full range of comprehensive and subspecialty services and the facility is fully equipped for surgery, procedures, imaging and diagnostics. The recent expansion to the Longwood Medical Area (LMA) has broadened and enhanced collaborations with LMA HMS Ophthalmology affiliates, neighborhood institutions and the community in general. Joslin Diabetes Center has co-located clinical offices there and Joslin physicians are now providing a full array of high quality, comprehensive and subspecialty eye care to ophthalmology patients who are at-risk for diabetes-related eye complications. Additionally, Mass. Eye and Ear, Longwood's closer proximity to Brigham and Women's (BWH) Hospital is speeding up communication with BWH physicians and the referral community, and providing faster access to care for patients. Led by Mass. Eye and Ear, Longwood Clinical Director, Carolyn Kloek, MD, several open houses were held before and after the Longwood facility opening to introduce the facility and staff to the neighboring hospital and referring physician community. Mass. Eye and Ear, Longwood is now well integrated into the community and is ready resource for nearby medical practices whose clinicians are operating in the facility's new surgical suite and utilizing its ophthalmic imaging and testing resources. - Mass. Eye and Ear and MGH Streamline Care for Patients with Diabetic Eye Disease. Mass. Eye and Ear and Mass General Hospital have collaborated to implement a new, streamlined patient care process for MGH patients who require an OPTOS diabetic eye screening or a diabetic eye exam. A Mass General PCP or nurse practitioner initiates testing by filling out a Mass. Eye and Ear order form and directs patients to Mass. Eye and Ear's Fluorescein Department. MGH patients are given the next available photographer for processing. Images are uploaded to the Mass. Eye and Ear image viewing system and a clinical message is posted in the LMR to alert the MDs reading the test. Once they review and document the result, a clinical message is sent to the referring PCP at Mass. General. Results are provided within one week and - in the event of an abnormal result - Mass. Eye and Ear staff will contact the patient to coordinate an appointment. Patients with normal studies are notified by mail or via Patient Gateway. - Mass. Eye and Ear Expands Optometry Team. Mass. Eye and Ear continues to grow its cadre of optometrists in a strategic move to extend its patient base, partner with MDs to optimize patient scheduling and streamline care to patients. The Optometry service now includes six, full-time members. The two most recent recruits to the service - Mark Bernardo, OD, and Yan Jiang, OD, PhD - have established full-time practices at Mass. Eye and Ear, Longwood. - Mass. Eye and Ear Ranked a Top Specialty Hospital. Since 1990, Mass. Eye and Ear has been one of the top ranked hospitals in the nation for ophthalmology, according to U.S. News & World Report magazine's "America's Best Hospitals" 2013 survey. This year, Mass. Eye and Ear, Massachusetts General Hospital ranked #4 in Ophthalmology. - Mass. Eye and Ear to Release the 4th Annual Quality and Outcomes Report. Mass. Eye and Ear prepared its 4th Annual Quality and Outcomes Report, documenting clinical and surgical outcomes data for key Ophthalmology procedures. The 2013 Quality and Outcomes Report (the third combined Ophthalmology/ENT report) will provide a full view of our highly specialized care and surgery, while cataloguing measures that continue to establish industry benchmarks nationwide. - New Equipment and Technology: - Retina Service: The next-generation Canon Adaptive Optics Scanning Laser Ophthalmoscope (not yet in clinical use) has the potential to resolve individual cone cells in the retina, enabling clinicians to monitor progression of diseases of the retina to a degree never before possible. - Retina/Glaucoma Service: TopCon Swept Source OCT allows the detection and resolution of individual retinal layers and is particularly helpful in retinal diseases such as wet AMD. This new technology has the potential to distinguish single photoreceptors in the retina with the potential for better resolution of sub-RPE images.	CLINICAL CARE
COMMUNITY SERVICE:	- Support Groups - Mass. Eye and Ear Eye Plastics hosted a quarterly Thyroid Eye Disease support group, which is led by Suzanne Freitag, MD. This support group is run in collaboration with the Graves Disease and Thyroid Foundation along with MGH endocrinology and Dr. Greg Randolph of Mass. Eye and Ear ENT. - Mass. Eye and Ear Vision Rehabilitation Support Group runs weekly for 8 weeks in the Vision Rehabilitation Clinic, and is led by a Mass. Eye and Ear social worker and a social worker who has low vision. - Community Forums, Lectures and Special Events - Ula Jurkunas, MD, and Michael Young, PhD, presented a seminar entitled, "The Stem Cell Stories: Revolutionary Results from Boston-area Researchers," at a free public forum sponsored by the Harvard Stem Cell Institute as part of the International Society for Stem Cell Research's 11th Annual Meeting. The seminar was held at the OMNI Parker House in Boston on June 11, 2013. - On June 22, 2013 Lucy Shen, MD gave a talk to the New England Chapter of the Glaucoma Foundation on the importance and meaning of glaucoma tests. - Screenings - In conjunction with Vision Coalition, Mass. Eye and Ear provided dilated eye exams and eyeglasses for students from the Year Up program in July at both the main campus and at Longwood. Mark Bernardo, OD, Angela DuBois, Myrna Duran, Nolette Ferjuste, Alexander Lascko, Do Lee and Amy Watts, OD participated in this important program. - Community Benefits vision screenings for students at Camp Harbor View (18th Year) were held July 23 and August 9, 2013. Staff from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation screened 235 children in total, with 78 requiring follow-up care. - A team from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation visited the Neighborhood House Charter School on October 11, 2013 and provided more than 320 screenings. Mass. Eye and Ear has provided vision and hearing screenings to the children at this Boston school as part of its community benefits program since the school opened in 1995. Dr. Ankoor Shah and Chief Ophthalmic Tech, Shakhsanam Aliyeva led the team of residents, technicians and staff who helped with the event.	LOCAL/REGIONAL:
OTOLARYNGOLOGY:	- New Equipment and Technology: - An exciting milestone in our educational efforts, construction on our new state-of-the-art otolaryngology surgical training laboratory was completed early this year. The Joseph B. Nadol, Jr., M.D., Otolaryngology Surgical Training Laboratory allows for advanced instruction capabilities in nearly every subspecialty of otolaryngology and will serve as a resource for our residents and fellows, as well as experienced surgeons in continuing medical education. - Derrick Lin, M.D., and James Rocco, M.D., Ph.D., have pioneered efforts toward bringing transoral robotic surgery to appropriate head and neck cancer patients at Mass. Eye and Ear. Drs. Lin and Rocco now offer this treatment using facilities at Winchester Hospital, which is located in the northwest suburb of Boston. Radiology: - New Equipment and Technology: - A trial of a 3D Accuitomo CT system continued through FY13 and will continue in FY14. This is a no cost trial in an effort to work with the manufacturer to improve temporal bone scans and image resolution. Referring MD's have responded positively on the increased quality of images for these non-contrast studies. An evaluation to lease or purchase the system will be performed in FY14. - We are in the final evaluation stage to select a new CT system vendor (GE or Siemens) in an effort to replace the existing Siemens Somatom 40-slice CT system. The current system is nearing end of life and is approaching eight years old. The new CT system will be implemented in FY14.
FORM 990, PART VI, LINE 1A:	THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION").	THE INFIRMARY'S BYLAWS STATE THE FOLLOWING:
FORM 990, PART VI, LINE 7B:	THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY.
FORM 990, PART VI, LINE 11B:	THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING.
FORM 990, PART VI, LINE 12C:	MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH.
FORM 990, PART VI, LINE 15:	THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE.
FORM 990, PART VI, LINE 19:	SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: PERIODIC PENSION COST $11,881,769

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (6 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivities	Legal Domicile StateLegalDomicileState	Exempt Code SectionExemptCodeSection	Public Charity StatusPublicCharityStatus	Business Name Line1DirectControllingEntityName/BusinessNameLine1	Controlled OrgControlledOrg
FDN OF THE MASS EYE & EAR INFIRMARYINC
243 CHARLES STREET	BOSTON	MA	02114	042785453	PARENT	MA	501(C)(3)	9	NA	false
MASSACHUSETTS EYE & EAR ASSOCIATES INC
243 CHARLES STREET	BOSTON	MA	02114	222658209	PATIENT CARE	MA	501(C)(3)	9	FOUNDATION	true
CIRCLE COMPANY INC
243 CHARLES STREET	BOSTON	MA	02114	042801791	TITLE HOLDING	MA	501(C)(25)	N/A	FOUNDATION	true
EMBANKMENT SERVICES INC
14 DAVID G MUGAR WAY	BOSTON	MA	02114	043272865	SUPPORTNG ORG	MA	501(C)(3)	11 - TYPE 1	FOUNDATION	true
MASS EYE & EAR INFIRMARY PENSION PLAN
243 CHARLES STREET	BOSTON	MA	02114	046067238	PENSION PLAN	MA	401(A)	N/A	NA	false
SCHEPENS EYE RESEARCH INSTITUTE INC
20 STANIFORD STREET	BOSTON	MA	02114	042129889	RESEARCH	MA	501(C)(3)	7	FOUNDATION	true

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	false	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	true	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	true	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	false	LoansOrGuaranteesFromOtherOrg
Dividends Related Organization	false	DividendsRelatedOrganization
Sale Of Assets To Other Org	false	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	false	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	false	ExchangeOfAssets
Rental Of Facilities To Other Orgs	false	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	true	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	false	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	true	PerformOfServicesByOtherOrgs
Sharing Of Facilities	false	SharingOfFacilities
Sharing Of Paid Employees	true	SharingOfPaidEmployees
Reimbursement Paid To Other Org	true	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	true	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	true	OtherTransferToOtherOrg
Other Transfer From Other Org	false	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (13 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved	Method Of Amt DeterminationMethodOfAmtDetermination
CIRCLE COMPANY INC
K	25000	CASH
CIRCLE COMPANY INC
O	132054	CASH
CIRCLE COMPANY INC
Q	145000	CASH
EMBANKMENT SERVICES INC
Q	1170593	CASH
EMBANKMENT SERVICES INC
O	1389268	CASH
MASSACHUSETTS EYE AND EAR PENSION PLAN
R	8204000	CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
Q	28713700	CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
B	9966948	CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
C	80395	CASH
SCHEPENS EYE RESEARCH INSTITUTE INC
C	570606	CASH
SCHEPENS EYE RESEARCH INSTITUTE INC
Q	1124366	CASH
SCHEPENS EYE RESEARCH INSTITUTE INC
P	800674	CASH
MASSACHUSETTS EYE AND EAR ASSOCIATES INC
O	8739754	CASH

Form990 Schedule R Part VII Form990ScheduleRPartVII

Field	Value	IRS element (for citing)
Identifier	SCHEDULE R, PART V, LINE 15:	Identifier
Explanation	CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.	Explanation